2023 Annual Meeting | P5 - Poster Session 5

Date Monday 04/24/23

Time 11:45 AM - 12:45 PM EST Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Scientific Poster Session

Topic(s) Sleep, Aging, Dementia, and Behavioral Neurology, Autoimmune Neurology, Child Neurology and Developmental Neurology, Education, Research, and Methodology, Epilepsy/Clinical Neurophysiology (EEG), General Neurology, Health Care Disparities, Infectious Disease, Movement Disorders, Multiple Sclerosis, Neuro Trauma and Critical Care, Neuromuscular and Clinical Neurophysiology (EMG)

CME Available 0.00 CME credit

Event Timeline
11:45 AM - 12:45 PM EST	Abstract	9-001 - Is Thalamic DBS Synergistic With VNS in Drug Resistant Genetic Generalized Epilepsy? Aafreen Khan, MD
11:45 AM - 12:45 PM EST	Abstract	9-002 - Efficacy and Quality of Life Outcome of Combined Epilepsy Surgery with RNS Placement Jie Pan, MD
11:45 AM - 12:45 PM EST	Abstract	9-003 - Thalamic neuromodulation outcomes in drug-resistant refractory epilepsy with Deep Brain Stimulation and Responsive Neurostimulation Rohit Das, MD, FAAN
11:45 AM - 12:45 PM EST	Abstract	9-004 - Clinical Outcomes in Combined Epilepsy Surgery and Responsive Neurostimulation Anna Zolyan, MD
11:45 AM - 12:45 PM EST	Abstract	9-005 - Responsive neurostimulation device use in patients with epilepsy and psychogenic non-epileptic events. Case report and Healthcare expenditure analysis related to neuromodulation therapy in Epilepsy patients Ahmad Sawalha, MD
11:45 AM - 12:45 PM EST	Abstract	9-006 - Scheduled Programming of VNS Therapy Reduces Time-To-Dose and Office Visits in the COVID-19 Pandemic Maxine Dibue-Adjei, PhD
11:45 AM - 12:45 PM EST	Abstract	9-007 - High Frequency Stimulation of the Centromedian Thalamic Nucleus to Abort Seizures and Interictal Discharges During Stereoelectroencephalography Evaluation Cody L. Nathan, MD
11:45 AM - 12:45 PM EST	Abstract	9-008 - Ictal Thalamic Recordings in Patients with Deep Brain Stimulation Targeting Thalamic Nuclei Lea Saab
11:45 AM - 12:45 PM EST	Abstract	9-009 - Is there a difference in reduction of seizure frequency between transcutaneous and traditional VNS? Jonadab Dos Santos Silva
11:45 AM - 12:45 PM EST	Abstract	9-010 - Deep Brain Stimulation in Hemimegalencephaly with Medically Intractable Epilepsy: A Case Report Delini Sivakumar, MD
11:45 AM - 12:45 PM EST	Abstract	9-011 - A Single-Center Evaluation of Responsive Neurostimulation as Treatment for Drug-resistant Epilepsy Sean T. Beattie, DO
11:45 AM - 12:45 PM EST	Abstract	9-012 - An educational intervention to improve the efficacy of responsive neurostimulation scans: a single-center study Roohi Katyal, MD
11:45 AM - 12:45 PM EST	Abstract	15-001 - Impact of Gender and Race on Academic Achievements for Neurology Faculty. Sima I. Patel, MD
11:45 AM - 12:45 PM EST	Abstract	15-002 - A Student-Faculty Collaboration for Authentic Teaching of the Effects of Discrimination on Brain Health Breanna Chachere
11:45 AM - 12:45 PM EST	Abstract	15-003 - Creation of a Faculty Development Curriculum to Reduce the Impact of Racial/Ethnic Bias on Medical Students Robert I. Thompson-Stone, MD, FAAN
11:45 AM - 12:45 PM EST	Abstract	15-004 - Feasibility of an Interactive Zoom-based Antiracism Course for Academic Neurology Faculty Neishay Ayub, MD
11:45 AM - 12:45 PM EST	Abstract	15-005 - Academic Vascular Neurology - Lingering Effect of Gender Inequity on Compensation, Career and Burnout Annie Z. He
11:45 AM - 12:45 PM EST	Abstract	15-006 - Parental Leave Experience for Academic Neurology Faculty at 19 Academic Centers Annie Z. He
11:45 AM - 12:45 PM EST	Abstract	3-002 - Multiple Sclerosis Research Across the African Continent: A Systematic Review Soonmyung Hwang
11:45 AM - 12:45 PM EST	Abstract	3-003 - Most Opticospinal Demyelination is NMOSD, not MS- A 17-year UK Longitudinal Cohort Study Mirasol Forcadela, MD
11:45 AM - 12:45 PM EST	Abstract	3-004 - Effect of endocrine disrupting chemicals on early disease course in Multiple sclerosis Tzu-ying Chuang, MD, PhD
11:45 AM - 12:45 PM EST	Abstract	3-005 - Idiosyncrasy in a Spanish-speaking developing country and Employment: study of general population and Multiple Sclerosis Sandra Vanotti
11:45 AM - 12:45 PM EST	Abstract	3-006 - Characteristics of Multiple Sclerosis Patients by Phenotype: A Cross-Sectional Analysis Using the CLIMB Study Gauruv Bose, MD
11:45 AM - 12:45 PM EST	Abstract	3-007 - Oral health-related quality of life in multiple sclerosis and neuromyelitis optica spectrum disorder patients from Argentina Veronica A. Tkachuk
11:45 AM - 12:45 PM EST	Abstract	3-008 - Investigating the Prevalence of Psychiatric Disorders in Multiple Sclerosis with Autoimmune Comorbidities Shin Chang
11:45 AM - 12:45 PM EST	Abstract	3-009 - Symptom Severity in Early-stage Relapsing Remitting Multiple Sclerosis Tamara Castillo-Trivino, MD, MAS, FAAN
11:45 AM - 12:45 PM EST	Abstract	3-010 - Correlations Between Early MRI Parameters and Long-term Clinical Outcomes in Phase 3 and Open-label Extension Studies of Ozanimod in Relapsing Multiple Sclerosis Jon Riolo, PhD
11:45 AM - 12:45 PM EST	Abstract	3-011 - Long-term Survival in Multiple Sclerosis is Improving Stig Wergeland, MD, PhD
11:45 AM - 12:45 PM EST	Abstract	3-012 - Use of individual measure and Z-scores to monitor disease course in Relapsing Multiple Sclerosis: A 1-year Prospective Study in a Single Center Luis Rafael Solís-Tarazona, MD
11:45 AM - 12:45 PM EST	Abstract	3-013 - Serum metabolic profile in early multiple sclerosis as predictor of long-term disease progression in BENEFIT Marianna Cortese, MD, PhD
11:45 AM - 12:45 PM EST	Abstract	3-014 - Cognitive Processing Speed Predicts Disability Milestones in Multiple Sclerosis Danielle M. Howard, MD
11:45 AM - 12:45 PM EST	Abstract	3-015 - Baseline predictors of disability worsening among patients wth a Clinically Isolated Syndrome. Enric Monreal Laguillo
11:45 AM - 12:45 PM EST	Abstract	3-016 - Serum Glial Fibrillary Acidic Protein compared with Neurofilament Light Chain as Biomarker for Multiple Sclerosis Disease Progression Stephanie V. Meier
11:45 AM - 12:45 PM EST	Abstract	3-017 - Predicting the Final Clinical Phenotype after the First Attack of Optic Neuritis Shlok Sarin, MD
11:45 AM - 12:45 PM EST	Abstract	3-018 - Patterns and Predictors of Multiple Sclerosis Phenotype Transitions: A Longitudinal Analysis Using the CLIMB Study Gauruv Bose, MD
11:45 AM - 12:45 PM EST	Abstract	12-001 - Two Cases of Anti-PD1 Antibody Associated Neurological Immune-Related Adverse Effects Grace E. Vitek, MD
11:45 AM - 12:45 PM EST	Abstract	12-002 - From WEMINO To WEBINO With Unilateral LMN Facial Palsy Rani Priyanka Vasireddy, MBBS
11:45 AM - 12:45 PM EST	Abstract	12-003 - Neurological Manifestations in Post Renal Transplant Patients at Sindh Institute of Urology and Transplantation, Pakistan Mughis Sheerani, MD
11:45 AM - 12:45 PM EST	Abstract	12-004 - CT IR Cyst Lumbar Rupture Efficacy (CIRCLE): A case series Katrina Bernardo, MD
11:45 AM - 12:45 PM EST	Abstract	12-005 - Direct Clinical Applications of Natural Language Processing in Common Neurological Disorders: A Systematic Review Ilana Lefkovitz, MD
11:45 AM - 12:45 PM EST	Abstract	12-006 - Validation of a Neurofilament Light Chain Assay on a Clinical Autoanalyzer Bradley Collier
11:45 AM - 12:45 PM EST	Abstract	12-007 - The Frequency of Symptoms in Patients with a Diagnosis of Degenerative Cervical Myelopathy: Results of a Scoping Review Lindsay Tetreault, MD, PhD
11:45 AM - 12:45 PM EST	Abstract	6-001 - Refractory anti-NMDA Receptor Encephalitis During Pregnancy: Treatment and Neonatal Outcome with Review of Literature Brandon J. Lew
11:45 AM - 12:45 PM EST	Abstract	6-002 - Persistent meningitis followed by anti-NMDAR encephalitis: case series and literature review Naoki Yamahara, MD
11:45 AM - 12:45 PM EST	Abstract	6-003 - Whole-exome sequencing shows no specific mutation in ovarian teratoma of NMDAR-antibody encephalitis Soo Hyun Ahn, MD
11:45 AM - 12:45 PM EST	Abstract	6-004 - A Case series with comparative analysis of children and young adults with Anti-N-Methyl-D-Aspartate Receptor Encephalitis Rani Priyanka Vasireddy, MBBS
11:45 AM - 12:45 PM EST	Abstract	6-005 - Characteristics and Treatment of anti-NMDAR Encephalitis in People Living with HIV: A Case Report and Literature Review Emily White, MD
11:45 AM - 12:45 PM EST	Abstract	6-006 - Longitudinal clinical outcomes, cognitive impairment, and mood symptoms in anti-NMDAR encephalitis Annalisa Morgan, MD
11:45 AM - 12:45 PM EST	Abstract	6-007 - Epidemiological and Demographic Characteristics Related to Social Determinants of Health in Patients with Anti-NMDAR Encephalitis Sarah Shapiro
11:45 AM - 12:45 PM EST	Abstract	6-008 - Anti-NMDAR encephalitis mimicking rapidly progressive neurodegenerative disorder in a toddler: a case report Linda Nguyen, MD, PhD
11:45 AM - 12:45 PM EST	Abstract	6-009 - Predicting Functional Outcome and Response to Therapy of Anti-NMDAR Encephalitis, Already at Diagnosis: The NEOS2 Model. Juliette Brenner, MD
11:45 AM - 12:45 PM EST	Abstract	6-010 - Post-Abortum NMDA Encephalitis Rozaleen Aleyadeh, MD
11:45 AM - 12:45 PM EST	Abstract	6-011 - Diagnostic Challenges in Pediatric Anti-NMDA Receptor Encephalitis Melissa A. Wright, MD
11:45 AM - 12:45 PM EST	Abstract	6-012 - Missing Piece of Puzzle: Electro-Convulsive Therapy (ECT) in Patients with anti-NMDA Receptor Encephalitis Lara C. Wadi, MD
11:45 AM - 12:45 PM EST	Abstract	6-013 - Biomarkers of Neuronal and Glial Injury in Leucine-Rich Glioma Inactivated-1 (LGI1) Autoimmune Encephalitis Patients: A Pilot Study Tyler L. Borko, BA
11:45 AM - 12:45 PM EST	Abstract	6-014 - A Pediatric Case of LGI1 Autoimmune Encephalitis Presenting with Faciobrachial Dystonic Seizures Cheryl Fields, DO
11:45 AM - 12:45 PM EST	Abstract	6-015 - Monitoring Faciobrachial Dystonic Seizures with Wearable Devices Benjamin H. Brinkmann, PhD
11:45 AM - 12:45 PM EST	Abstract	6-016 - Cerebrospinal fluid proteomics indicates immune dysregulation and neuronal dysfunction in antibody associated autoimmune encephalitis Saskia Raeuber, MD
11:45 AM - 12:45 PM EST	Abstract	6-017 - Structural Lesion Facade Hiding an Insidious Autoimmune Encephalitis Doris Xia, DO
11:45 AM - 12:45 PM EST	Abstract	6-018 - New method to detect a diagnostic marker anti-NH2–terminal of a–enolase autoantibody for Hashimoto’s encephalopathy Makoto Yoneda
11:45 AM - 12:45 PM EST	Abstract	6-019 - Prognosticating Outcomes in Patients with CRMP5-IgG Associated Paraneoplastic Neurologic Disorders Sanem P. Uysal, MD
11:45 AM - 12:45 PM EST	Abstract	6-020 - Sudden Death in Autoimmune GFAP Astrocytopathy Bishow Chandra Mahat, MD
11:45 AM - 12:45 PM EST	Abstract	6-021 - Incidental Detection of Anti-IgLON5: A Diagnostic and Therapeutic Dilemma Samir Alkabie, MD, MSc
11:45 AM - 12:45 PM EST	Abstract	6-022 - Diaphragmatic paralysis associated with IgLON5 autoimmunity Smathorn Thakolwiboon, MD
11:45 AM - 12:45 PM EST	Abstract	6-023 - An Atypical Presentation of GABA-B Encephalitis Mac DeHart-McCoyle, DO
11:45 AM - 12:45 PM EST	Abstract	6-024 - Case Report of Anti-DPPX Encephalitis: Diagnostic Challenges in Hematologic-Oncologic Comorbidities Emily R. Fisher, MD
11:45 AM - 12:45 PM EST	Abstract	6-025 - Anti-Tr/DNER Paraneoplastic Cerebellar Degeneration with Marked Cerebellar and Psychological Symptoms Responsive to Plasma Exchange Paul D. Crane, MD
11:45 AM - 12:45 PM EST	Abstract	6-026 - Paraneoplastic Neurologic Syndromes with ANNA-2/anti-Ri: a Contrasting Story of Two Cases Nanthaya Tisavipat, MD
11:45 AM - 12:45 PM EST	Abstract	6-027 - Clinical features and biomarkers of acute encephalitis with claustrum sign Naoki Yamahara, MD
11:45 AM - 12:45 PM EST	Abstract	6-028 - Anti-IgLON-5 Associated Neurological Disease Presenting with Bilateral Optic Neuritis, Orthostatic Intolerance, Sleep-Related Movements in Setting of Testicular Mass: Expanding Clinical Phenotypes in the Disease. Aditi V. Varma-Doyle, MD
11:45 AM - 12:45 PM EST	Abstract	6-029 - Clinical Manifestation, Auxiliary Examination Features and Prognosis of GFAP Autoimmunity:a Chinese Cohort Study Ka-Ho Wong
11:45 AM - 12:45 PM EST	Abstract	6-030 - A Rare Case of Anti-SOX1 Antibody Positive Paraneoplastic Cerebellar Degeneration in Prostate Cancer Hadi Mohammad Khanli, MD
11:45 AM - 12:45 PM EST	Abstract	6-031 - Expanded Spectrum of Gad-65 Associated Autoimmune Encephalitis in Pediatric Patients. Geetanjali S. Rathore, MD, FAAN
11:45 AM - 12:45 PM EST	Abstract	6-032 - Pediatric CLIPPERS? Think Again! Daniel Zhou, MD
11:45 AM - 12:45 PM EST	Abstract	7-001 - Decline in Visual and Posterior Cortical Functions in Logopenic Progressive Aphasia Neha Atulkumar Singh, PhD
11:45 AM - 12:45 PM EST	Abstract	7-002 - Beyond impairment of language: empathy deficit in logopenic variant of Primary Progressive Aphasia Giulia Giacomucci, MD
11:45 AM - 12:45 PM EST	Abstract	7-003 - Prevalence of Amyloid-Related Imaging Abnormalities in APOE4/4 Homozygotes with Early Alzheimer's Disease: Baseline Findings from Ongoing Clinical Trials of Oral Anti-Amyloid Agent ALZ-801 (Valiltramiprosate) Sawsan (Susan) R. Abushakra, MD
11:45 AM - 12:45 PM EST	Abstract	7-004 - A Novel Presenilin-1 Mutation Associated with Dementia and Spastic Paraplegia Bridget Ollesch, MD
11:45 AM - 12:45 PM EST	Abstract	7-005 - Clinical and Imaging Features of Early Onset Alzheimer’s Disease with a SORL1 Nonsense Variant Conor T. Flavin, MD
11:45 AM - 12:45 PM EST	Abstract	7-006 - Eligibility for Anti-Amyloid Treatment in a Population-Based Cohort Study of Aging Rioghna R. Pittock
11:45 AM - 12:45 PM EST	Abstract	7-007 - Early engagement with the Alzheimer’s disease (AD) community to gain insights into designing the SKYLINE trial in cognitively unimpaired people at risk for progression due to AD Gesine Respondek, MD
11:45 AM - 12:45 PM EST	Abstract	7-008 - A positive feedback loop between chronic lysosomal dysfunction and circRNAs in Alzheimer’s disease mouse models Skarleth Cardenas Romero, Jr., MD
11:45 AM - 12:45 PM EST	Abstract	7-009 - Identifying The Normal Function of Amyloid-Beta and Its Role in Alzheimer's Disease Rachel Hunsucker
11:45 AM - 12:45 PM EST	Abstract	7-010 - Associations Between CDR-Global and Meaningful Outcomes in Patients with Alzheimer’s Disease Christian Wichmann
11:45 AM - 12:45 PM EST	Abstract	7-011 - Medial Temporal Tau Predicts Memory Decline in Cognitively Unimpaired Elderly Angela T. Kwan, MSc
11:45 AM - 12:45 PM EST	Abstract	1-001 - Elucidating Mechanism of Ammonia Toxicity Using Cortical Organoids Shawn M. Barton, MD, PhD
11:45 AM - 12:45 PM EST	Abstract	1-002 - Predictors Of Outcome In ICH Patients Initially Admitted To The ICU Who Are Transferred To Inpatient Rehab Mohammad Jamil Ahmad, MD
11:45 AM - 12:45 PM EST	Abstract	1-003 - Antidepressant Use and Associations with Delirium in Patients with Intracerebral Hemorrhage Helen Y. Zhou
11:45 AM - 12:45 PM EST	Abstract	1-004 - Acute Loss Of Brain Stem Reflexes Following Intracranial Hemorrhage Stefano Malerba, MD
11:45 AM - 12:45 PM EST	Abstract	1-005 - Clinical Trajectories in Patients with Severe Acute Brain Injury Requiring Mechanical Ventilation: A Descriptive Analysis of a Single-Center Prospective Observational Cohort Study Natalie Smith, MD
11:45 AM - 12:45 PM EST	Abstract	1-006 - Long-Term Trajectories Following Severe Acute Brain Injury Requiring Mechanical Ventilation: A Mixed-methods Study to Assess Outcomes of Patients and Their Surrogate Decision-Makers Sarah Wahlster, MD
11:45 AM - 12:45 PM EST	Abstract	10-001 - Development and Validation of Machine Learning and Electronic Medical Records-Based Characterization of Stiff Person Syndrome Soo Hwan Park
11:45 AM - 12:45 PM EST	Abstract	10-003 - Autoimmune Isaac’s Syndrome With CASPR2 Antibodies Secondary To Mercury Toxicity Sanita Raju, MD
11:45 AM - 12:45 PM EST	Abstract	10-004 - Multisystem Proteinopathies (MSP) and MSP-like Disorders: Clinical-Pathological-Molecular Spectrum and Long-term Follow Up Pitcha Chompoopong, MD
11:45 AM - 12:45 PM EST	Abstract	10-005 - Clinical and Electrophysiological Presentation of a Patient with Multisystem Proteinopathy Associated with Valosin-Containing Protein Mutation Matthew Halber
11:45 AM - 12:45 PM EST	Abstract	10-006 - Investigation of the Circulating Cell-free Mitochondrial DNA in Inflammation Related Neuromuscular Diseases Can Ebru Kurt, MD
11:45 AM - 12:45 PM EST	Abstract	10-007 - A Rare Case of Kearns-Sayre Syndrome (KSS) with the Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes (MELAS) Phenotype Shaweta Khosa
11:45 AM - 12:45 PM EST	Abstract	10-008 - Progressive Longitudinally Extensive Myelopathy following Stroke in a Patient later found to have m.14484T>C Mutation in Leber’s Hereditary Optic Neuropathy (LHON) gene. Kathryn Eszes, MD
11:45 AM - 12:45 PM EST	Abstract	10-009 - Atypical Presentation of MELAS in a 7-year-old Male: A Case Report Muhammad Khurram Afzal, MD
11:45 AM - 12:45 PM EST	Abstract	10-010 - Twelve-month functional change in Limb Girdle Muscular Dystrophy R9 / 2I Nicholas E. Johnson, MD, FAAN
11:45 AM - 12:45 PM EST	Abstract	10-011 - Muscle Ultrasound in an Open-Label Study of Losmapimod in Subjects with FSHD1 Joost Kools, MD
11:45 AM - 12:45 PM EST	Abstract	10-012 - EMBARK, a Phase 3 Trial Evaluating Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) in Duchenne Muscular Dystrophy (DMD): Study Design and Baseline Characteristics Francesco Muntoni, MD
11:45 AM - 12:45 PM EST	Abstract	10-013 - Analysis of Vector Shedding Following Treatment with Delandistrogene Moxeparvovec (SRP-9001), an Investigational rAAVrh74-Based Gene Therapy for Duchenne Muscular Dystrophy (DMD) Xiaolan Zhang, Other
11:45 AM - 12:45 PM EST	Abstract	10-014 - Motor Performance and Lower Extremity Fat Fraction in Myotonic Dystrophies Type 1 and Type 2, and Controls Diana A. Madrid, MS
11:45 AM - 12:45 PM EST	Abstract	10-015 - Caregivers Perspectives on Multidisciplinary Clinic Visits for Duchenne and Becker Muscular Dystrophy Cade M. Haynie
11:45 AM - 12:45 PM EST	Abstract	4-001 - Social Work in Outpatient Neurology at a Safety-Net Hospital: A 200-Hour Profile Cayla Vila, MD
11:45 AM - 12:45 PM EST	Abstract	4-002 - US Census Tracts with Higher Proportions of Hispanics, Individuals with Disabilities, and Rural Location have Worse Geospatial Access to Neurological Care Marisa P. McGinley, DO
11:45 AM - 12:45 PM EST	Abstract	4-003 - Diversity, Equity, and Inclusion (DEI) Curriculum for Neurology Residency Program Diana Andino, MD
11:45 AM - 12:45 PM EST	Abstract	4-004 - Diversity, Equity, and Inclusion in Local Clinical Trials Saketh Annam, MBBS
11:45 AM - 12:45 PM EST	Abstract	4-005 - The Impact of Establishing a Diversity, Equity, and Inclusion Committee in a Single US Adult Neurology Residency Program Mathura Ravishankar, MD
11:45 AM - 12:45 PM EST	Abstract	4-006 - Broad Inclusion of Roles for a Neurology Department Diversity, Equity, and Inclusion Committee: Working Towards a Future of DEI Throughout Medicine Olajide Abiola, MD
11:45 AM - 12:45 PM EST	Abstract	4-007 - Increasing Ecopipam Exposure Improves Yale Global Tic Severity Scale-Total Tic Scores (YGTSS-TTS) in Children and Adolescents with Tourette Syndrome (TS): Results from a Population Pharmacokinetic (popPK) Model-Based Simulation Using D1AMOND Trial Data Stephen Wanaski, PhD
11:45 AM - 12:45 PM EST	Abstract	4-008 - Biofeedback-based Video Game Device to Treat Rage Attacks in Youth with Tourette Syndrome Matthew Tae
11:45 AM - 12:45 PM EST	Abstract	4-009 - High Dose Clonidine as a Novel Therapy for Symptomatic Status Dystonicus in a Pediatric Patient Sean B. Woods
11:45 AM - 12:45 PM EST	Abstract	4-010 - Pediatric opsoclonus myoclonus ataxia syndrome in the setting of COVID-19 Maayan J. Yakir, MD
11:45 AM - 12:45 PM EST	Abstract	4-011 - Painful Hemidystonia - A Rare Presentation of Uremic Encephalopathy Manasa Sudheendra, MBBS
11:45 AM - 12:45 PM EST	Abstract	4-012 - Identifying Upper Extremity Features of Dystonia in People with Cerebral Palsy Laura Gilbert, DO, MBA
11:45 AM - 12:45 PM EST	Abstract	13-001 - The Experience of The COVID-19 Pandemic in a Population-Based Study of Cognitive Aging Khaled Ghoniem, MD
11:45 AM - 12:45 PM EST	Abstract	13-002 - COVID-19 Induced Elimination of First Taste Phenomenon Drushti D. Birwatkar
11:45 AM - 12:45 PM EST	Abstract	13-003 - Neurological manifestations in COVID-19 survivors: Observations in one of the largest only COVID-19 centers in México. Monica Saray R. Rodríguez, Sr., MD
11:45 AM - 12:45 PM EST	Abstract	13-004 - The Analysis of 607 Volunteers Shows a Reduction of Workability in Individuals With LONG-COVID Syndrome Associated With Neuropsychiatric Symptoms Lucas S. Silva, MD
11:45 AM - 12:45 PM EST	Abstract	13-005 - Body mass index and its association with COVID-19 clinico-neurological outcomes: Findings from the Philippine CORONA study Adrian I. Espiritu, MD
11:45 AM - 12:45 PM EST	Abstract	13-006 - Men with dementia are at increased risk of all-cause mortality following SARS-CoV-2 Vaccination Jin Myoung Seok, MD
11:45 AM - 12:45 PM EST	Abstract	5-001 - Antibiotic exposure and risk of Parkinson's disease in the United Kingdom: A case-control study Gian D. Pal, MD
11:45 AM - 12:45 PM EST	Abstract	5-002 - Neurophysiological Measures can be Used as Stratification Tool for Parkinson’s Disease Subtypes Inbal Maidan, PhD
11:45 AM - 12:45 PM EST	Abstract	5-003 - Categorizing Movement Disorders Associated with Toxic Exposures at Camp Lejeune Military Base Jacqueline Hirschey, MD
11:45 AM - 12:45 PM EST	Abstract	5-004 - Assessing the swallow tail sign in a real life scenario Maria Agustina Ruiz Yanzi, MD
11:45 AM - 12:45 PM EST	Abstract	5-005 - Partially reversible bilateral Lenticular fork sign and acute Parkinsonism in diabetic uremic syndrome Yazan Nofal, MD
11:45 AM - 12:45 PM EST	Abstract	5-006 - Amyloid plaque burden and dual tasking impairments on the Timed up and go test in Parkinson disease Ashley Harrie
11:45 AM - 12:45 PM EST	Abstract	5-007 - DaT Scan Positive Parkinson’s Disease in a Patient with Anti-MuSK Positive Myasthenia Gravis Nada Ahmed, MD
11:45 AM - 12:45 PM EST	Abstract	5-008 - Treatment Perceptions and Decision-Making Among Physicians Treating Essential Tremor Margaret Gerbasi, PhD
11:45 AM - 12:45 PM EST	Abstract	5-009 - Fragile-X-associated Tremor/Ataxia Syndrome in a Woman with Full Mutation: A Case Report Serdar Kazanci, MD
11:45 AM - 12:45 PM EST	Abstract	5-010 - Palato-ocular synchrony: Seeing what is behind closed eyelids in palatal tremor Stephen G. Reich, MD, FAAN
11:45 AM - 12:45 PM EST	Abstract	5-011 - Cyst Formation following DBS Electrode Placement: A Rare Complication Mustafa S. Siddiqui, MD, FAAN
11:45 AM - 12:45 PM EST	Abstract	5-012 - Does chromosome 16p12.1-p12.2 harbor a novel gene for essential tremor? Muhammad I. Yousaf, MD
11:45 AM - 12:45 PM EST	Abstract	5-013 - Utilization of intraoperative Subthalamic Nucleus local field potential recordings to guide postoperative Deep Brain Stimulation programming in Parkinson’s disease Shumaila Anwer, MD
11:45 AM - 12:45 PM EST	Abstract	5-014 - Association of Subthalamic Beta Frequency Sub-bands to Symptom Severity in Patients with Parkinson’s Disease: A Systematic Review Rebekah L. Summers, PhD, PT
11:45 AM - 12:45 PM EST	Abstract	5-015 - Patient perceptions and knowledge of Deep Brain Stimulation (DBS) in Parkinson’s disease (PD) (KNOW-DBS) Austin Oblack, DO
11:45 AM - 12:45 PM EST	Abstract	5-016 - Are Cognitively Impaired Patients Selectively Recruited to Pallidal Deep Brain Stimulation (DBS) in Parkinson’s Disease (PD)? Sarah Marmol, MD
11:45 AM - 12:45 PM EST	Abstract	5-017 - Real-World Outcomes in USA using DBS Systems with Directionality and Multiple Independent Current Control Michael S. Okun, MD, FAAN
11:45 AM - 12:45 PM EST	Abstract	2-001 - Improving Early Recognition of Potentially Treatable Causes of Rapidly Progressive Dementia Nihal Satyadev, MD, MPH
11:45 AM - 12:45 PM EST	Abstract	2-002 - Clinical Experience with SATURN, a Public Domain Self-administered Cognitive Screening Test David P. Bissig, MD
11:45 AM - 12:45 PM EST	Abstract	2-003 - Cognitive Assessment is Feasible After Acute Stroke and Can Identify Co-occurrence of Spatial Neglect
11:45 AM - 12:45 PM EST	Abstract	2-004 - The contribution of thalamic pathology to the clinical manifestations of frontotemporal dementia phenotypes Eoin Finegan, MBBS
11:45 AM - 12:45 PM EST	Abstract	2-006 - A comprehensive cognitive profile of patients with cervical dystonia Shameer Rafee, MBBS
11:45 AM - 12:45 PM EST	Abstract	2-007 - Towards a Trauma Subtype of Functional Neurological Disorder: Impact on Symptom Severity and Physical Health David L. Perez, MD, FAAN
11:45 AM - 12:45 PM EST	Abstract	2-008 - The Effects of Anesthesia on Post-Operative Cognitive Dysfunction: A Systematic Review Rayan S. Hassan, PhD
11:45 AM - 12:45 PM EST	Abstract	2-009 - Analysis of Alzheimer’s Cerebrospinal Fluid Markers in Idiopathic Normal Pressure Hydrocephalus Pre- and Post-High Volume Lumbar Puncture Lealani M. Acosta, MD, MPH, FAAN
11:45 AM - 12:45 PM EST	Abstract	2-010 - RT-QuIC Testing for Prions: Applying a Sensitive but Imperfect Test in Clinical Practice Gregory S. Day, MD, MSc, FAAN
11:45 AM - 12:45 PM EST	Abstract	11-001 - Effects of Low-Sodium Oxybate on 24-Hour Total Sleep Time: Data From a Phase 3 Clinical Study in Adults With Idiopathic Hypersomnia Marisa Whalen
11:45 AM - 12:45 PM EST	Abstract	11-002 - Increased Risk of Hypertension Onset Among Patients With Narcolepsy Newly Treated With High-Sodium Oxybate Wayne Macfadden, MD, PT
11:45 AM - 12:45 PM EST	Abstract	11-003 - Effectiveness and Optimization of Low-Sodium Oxybate in Participants With Narcolepsy Switching From High-Sodium Oxybate: Interim Data from the Substitution of Equal Grams of Uninterrupted Xyrem to Xywav (SEGUE) Study Shawn A. Candler, MD
11:45 AM - 12:45 PM EST	Abstract	11-004 - Patient Preference and Nocturnal Experience With Oxybate Treatment for Narcolepsy: Interim Analysis of Data From RESTORE John Harsh, PhD
11:45 AM - 12:45 PM EST	Abstract	11-005 - Long-Term Safety of Once-Nightly Sodium Oxybate: Interim Analysis of Data From RESTORE John Harsh, PhD
11:45 AM - 12:45 PM EST	Abstract	11-006 - Long-term Safety During a Clinical Trial of Low-Sodium Oxybate in Participants With Narcolepsy With Cataplexy Nancy R. Foldvary-Schaefer, DO, FAAN

Faculty Disclosures
Sanita Raju, MD	Dr. Raju has nothing to disclose.
Sang Kun Lee, MD	Prof. Lee has nothing to disclose.
Sneha Mantri, MD, MS	Dr. Mantri has received personal compensation in the range of $0-$499 for serving as a Consultant for Deep Brain Innovations, LLC. Dr. Mantri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grey Matter Technology. The institution of Dr. Mantri has received research support from The Michael J Fox Foundation for Parkinson Research.
	No disclosure on file
Cynthia X. Wang, MD	Dr. Wang has nothing to disclose.
Tanuja Chitnis, MD, FAAN	Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Chitnis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche-Genentech. Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Siemens. Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Biosciences. Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Academic CME. The institution of Dr. Chitnis has received research support from Novartis. The institution of Dr. Chitnis has received research support from Sanofi. The institution of Dr. Chitnis has received research support from Octave. The institution of Dr. Chitnis has received research support from Genentech-Roche.
Ronald C. Petersen, MD, PhD, FAAN	Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nestle. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to AAN interests or activities.
Gregory S. Day, MD, MSc, FAAN	Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Parabon Nanolabs. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys Therapeutics. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for DynaMed (EBSCO Health). Dr. Day has stock in ANI Pharmaceuticals. The institution of Dr. Day has received research support from National Institutes of Health / NIA. The institution of Dr. Day has received research support from Chan Zuckerberg Initiative. The institution of Dr. Day has received research support from Alzheimer's Association. The institution of Dr. Day has received research support from National Institutes of Health / NINDS. The institution of Dr. Day has received research support from Amgen Pharmaceuticals. The institution of Dr. Day has received research support from AVID Radiopharmaceuticals. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Presenter at Annual Meeting (CME) with American Academy of Neurology. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Content Development (CME) with PeerView, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Continuing Education, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Ionis Pharmaceuticals. Dr. Day has a non-compensated relationship as a Clinical Director with AntiNMDA Receptor Encephalitis Foundation that is relevant to AAN interests or activities.
Kavita Nair, PhD, FAAN	Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Nair has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for PhRMA Foundation. Dr. Nair has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MJH Healthcare. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Anylam . Dr. Nair has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi-Genzyme. The institution of Dr. Nair has received research support from Genentech. The institution of Dr. Nair has received research support from Novartis. The institution of Dr. Nair has received research support from Genentech. The institution of Dr. Nair has received research support from Phrma Foundation. The institution of Dr. Nair has received research support from Bristol Meyers Squibb. The institution of Dr. Nair has received research support from Novartis. The institution of Dr. Nair has received research support from NINDS.
Jelena M. Pavlovic, MD, PhD	Dr. Pavlovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven.
Sean J. Pittock, MD	Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech, Inc.. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage Therapeutics, Inc.. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prime Therapeutics. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche/Genentech. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MedImmune/Viela Bio. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys Therapeutics. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche/Genentech. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB, Inc. Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffman/LaRoche AG. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genetech. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for F. Hofman/LaRoche. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arialys. The institution of Dr. Pittock has received research support from Grifols. The institution of Dr. Pittock has received research support from NIH. The institution of Dr. Pittock has received research support from Viela Bio/MedImmune/Horizon. The institution of Dr. Pittock has received research support from Alexion Pharmaceuticals. The institution of Dr. Pittock has received research support from F. Hoffman/LaRoche/Genentech. The institution of Dr. Pittock has received research support from NovelMed. The institution of Dr. Pittock has received research support from AstaZeneca. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received publishing royalties from a publication relating to health care.
Deanna Saylor, MD, MHS	The institution of Dr. Saylor has received research support from National Institutes of Health. The institution of Dr. Saylor has received research support from National Multiple Sclerosis Society. The institution of Dr. Saylor has received research support from American Academy of Neurology. The institution of Dr. Saylor has received research support from United States Department of State. Dr. Saylor has a non-compensated relationship as a Member of multiple committees and task forces focused on improving access to MS medications to people across the world with Multiple Sclerosis International Federation that is relevant to AAN interests or activities. Dr. Saylor has a non-compensated relationship as a Member of the Neurology and COVID19 committee with World Health Organization that is relevant to AAN interests or activities. Dr. Saylor has a non-compensated relationship as a Member of the International Outreach Committee, Junior and Early Career Membership Committee, and Educational Innovation Commitees with American Neurological Association that is relevant to AAN interests or activities.
Michael J. Thorpy, MD	Dr. Thorpy has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz. Dr. Thorpy has received publishing royalties from a publication relating to health care.
Nikolai Gil D. Reyes, MD	Dr. Reyes has nothing to disclose.
Maria A. Garcia-Dominguez, MD	Dr. Garcia-Dominguez has nothing to disclose.
Mar Guasp, MD	Dr. Guasp has nothing to disclose.
Saskia Raeuber, MD	Dr. Raeuber has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Healthcare Germany GmbH. The institution of Dr. Raeuber has received research support from Stiftung zur Förderung junger Neurowissenschaftler. The institution of Dr. Raeuber has received research support from Novartis.
Anna Marisa Cervantes-Arslanian, MD, FAAN	Dr. Cervantes-Arslanian has nothing to disclose.
Nadia Khalil, MD	Dr. Khalil has received personal compensation in the range of $0-$499 for serving as a Resident and Fellow Council Member with American Association of Neuromuscular & Electrodiagnostic Medicine. Dr. Khalil has received personal compensation in the range of $0-$499 for serving as a MS Mentorship Forum Participant with Foundation of the Consortium of Multiple Sclerosis Centers.
Mathura Ravishankar, MD	Dr. Ravishankar has nothing to disclose.
Farwa Ali, MD	Dr. Ali has nothing to disclose.
Olga Carmona	No disclosure on file
Anna Zolyan, MD	Dr. Zolyan has nothing to disclose.
Takahiro Iizuka, MD	The institution of Dr. Iizuka has received research support from Astellas Pharma Inc.
Stefan Sillau	No disclosure on file
Jeffrey L. Bennett, MD, PhD, FAAN	Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immpact Bio. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Chugai. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Beigene. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imcyse. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MIAC. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CorEvitas. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Vindico. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Touch IME. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Efficient LLC. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Pavich. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Marie Bush. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Marks Gray. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Knight, Nicastro, MacKay. The institution of Dr. Bennett has received research support from Alexion. Dr. Bennett has received intellectual property interests from a discovery or technology relating to health care. Dr. Bennett has received publishing royalties from a publication relating to health care.
Parneet K. Grewal, MD	Dr. Grewal has nothing to disclose.
Laura Gilbert, DO, MBA	Dr. Gilbert has nothing to disclose.
Pria Anand, MD	Dr. Anand has nothing to disclose.
Jennifer R. Friedman, MD	An immediate family member of Dr. Friedman has received personal compensation in the range of $0-$499 for serving as a Consultant for Sinopia Biosciences. An immediate family member of Dr. Friedman has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Pet Dx. Dr. Friedman has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. Dr. Friedman has stock in Friedman Bioventure .
Rupert Sandbrink, MD, PhD	Dr. Sandbrink has received personal compensation for serving as an employee of Topas Therapeutics. Dr. Sandbrink has received personal compensation for serving as an employee of Vico Therapeutics. Dr. Sandbrink has received stock or an ownership interest from Forward Pharma. Dr. Sandbrink has received stock or an ownership interest from Topas Therapeutics. Dr. Sandbrink has received stock or an ownership interest from Vico Therapeutics. Dr. Sandbrink has received stock or an ownership interest from Bayer.
Shahd H. Hamid, MBBS	Dr. Hamid has nothing to disclose.
Gilles Edan	Gilles Edan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Gilles Edan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Gilles Edan has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen. Gilles Edan has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck.
Elizabeth Chertavian	No disclosure on file
Abigail S. Bose, MD	Dr. Bose has nothing to disclose.
Jonathan Jagid	Jonathan Jagid has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Miami Dade County State Attorneys office. The institution of Jonathan Jagid has received research support from Boston Scientific.
Fabreena Napier, MD	Dr. Napier has nothing to disclose.
Marianna Cortese, MD, PhD	Dr. Cortese has received personal compensation in the range of $500-$4,999 for serving as a speaker at educational event with Roche.
Bruce A. Cree, MD, PhD, MCR, FAAN	The institution of Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Autobahn. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avotres. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon. Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neuron23. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Pharma. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal/Sandoz. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyverna. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Pharma. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic AG. The institution of Dr. Cree has received research support from Genentech. The institution of Dr. Cree has received research support from Kyverna. Dr. Cree has received publishing royalties from a publication relating to health care.
Anna Castillo	No disclosure on file
Smathorn Thakolwiboon, MD	Dr. Thakolwiboon has nothing to disclose.
Rodger J. Elble, MD, PhD, FAAN	Dr. Elble has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz. Dr. Elble has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage . Dr. Elble has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ES Therapeutics. Dr. Elble has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Applied Therapeutics. Dr. Elble has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Praxis.
Tonse Ashwini Kini, MBBS	Dr. Kini has nothing to disclose.
Camilo A. Gutierrez, MD, FAAN	Dr. Gutierrez has received research support from American academy of Neurology. Dr. Gutierrez has received personal compensation in the range of $0-$499 for serving as a Speaker with American Epilepsy Society.
Eoin P. Flanagan, MBBCh, FAAN	The institution of Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. The institution of Dr. Flanagan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pharmacy times. The institution of Dr. Flanagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Flanagan has received research support from Viela Bio. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Roche. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has a non-compensated relationship as a Member of medical Advisory Board with The MOG Project that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Journal of The Neurologic Sciences that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Neuroimmunology Reports that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology, Neuroimmunology Neuroinflammation (N2) Journal that is relevant to AAN interests or activities.
A. M. Barrett, MD, FAAN	The institution of Dr. Barrett has received research support from Veterans Health Association. The institution of Dr. Barrett has received research support from National Institutes of Health. The institution of Dr. Barrett has received research support from Mabel H Flory Trust. Dr. Barrett has received personal compensation in the range of $0-$499 for serving as a author, chapter with WebMD.
Daniel R. Gold, DO	Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer . Dr. Gold has received publishing royalties from a publication relating to health care.
Lealani M. Acosta, MD, MPH, FAAN	Dr. Acosta has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Acosta has received research support from AbbVie, Biohaven, Roche, NIH.
Shawn M. Barton, MD, PhD	Dr. Barton has nothing to disclose.
Anne Marie Morse	No disclosure on file
Venka Veerappan, MD	Dr. Veerappan has nothing to disclose.
Riccardo Galbusera	No disclosure on file
Fady Mousa-Ibrahim, DO	Dr. Mousa-Ibrahim has nothing to disclose.
Sean T. Beattie, DO	Dr. Beattie has nothing to disclose.
Sarah E. Nelson, MD, MPH, FAAN	Dr. Nelson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Spark Healthcare. Dr. Nelson has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Healthcare. Dr. Nelson has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Journal. Dr. Nelson has received publishing royalties from a publication relating to health care. Dr. Nelson has a non-compensated relationship as a Women Leading in Neurology Program with American Academy of Neurology that is relevant to AAN interests or activities.
Stacey Clardy, MD, PhD, FAAN	Dr. Clardy has received personal compensation for serving as an employee of Veterans Health Administration (VHA). Dr. Clardy has received personal compensation for serving as an employee of University of Utah Health. Dr. Clardy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca/Alexion. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen/Horizon. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arialys. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Clardy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology/AAN Publications. The institution of Dr. Clardy has received research support from NIH/NINDS. The institution of Dr. Clardy has received research support from SRNA. The institution of Dr. Clardy has received research support from Alexion/AstraZeneca. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a AAN Summer Meeting CoDirector Travel and Lodging with AAN. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with U of Iowa, Miami, Stanford, Barrow, Beaumont Health, CCF, Emory, Penn State, Mayo Clinic, Walter Reed.
Deborah Hall, MD, PhD, FAAN	Dr. Hall has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. Dr. Hall has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier - Parkinsonism and Related Disorders. Dr. Hall has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology. The institution of Dr. Hall has received research support from Parkinson's Foundation. The institution of Dr. Hall has received research support from CHDI. The institution of Dr. Hall has received research support from Neurocrine. The institution of Dr. Hall has received research support from Uniqure. The institution of Dr. Hall has received research support from SAGE. The institution of Dr. Hall has received research support from NIH.
Nathalie Jette, MD, MSc, FRCPC, FAAN	Dr. Jette has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ILAE Epilepsia. The institution of Dr. Jette has received research support from NIH. The institution of Dr. Jette has received research support from AES.
Geetanjali S. Rathore, MD, FAAN	Dr. Rathore has nothing to disclose.
Adrian I. Espiritu, MD	Dr. Espiritu has nothing to disclose.
Muhammad Khurram Afzal, MD	Dr. Afzal has nothing to disclose.
Rani Priyanka Vasireddy, MBBS	Dr. Vasireddy has nothing to disclose.
Amy Kunchok, MBBS	Dr. Kunchok has received personal compensation in the range of $0-$499 for serving as a Consultant for EMD Serono. Dr. Kunchok has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon therapeutics . Dr. Kunchok has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Kunchok has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology.
Ernst-Wilhelm Radue, MD	Dr. Radue has nothing to disclose.
Afsaneh Shirani, MD	Dr. Shirani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics.
Frances Weaver	No disclosure on file
Francesco Muntoni, MD	Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sarepta. Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer. Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Avexis. Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Muntoni has received research support from European Commission. The institution of Dr. Muntoni has received research support from Medical Research Council. The institution of Dr. Muntoni has received research support from Biogen. The institution of Dr. Muntoni has received research support from Muscular Dystrophy UK. The institution of Dr. Muntoni has received research support from MDA USA. The institution of Dr. Muntoni has received research support from Sarepta. The institution of Dr. Muntoni has received research support from Association Francoise Myopathies. Dr. Muntoni has received personal compensation in the range of $0-$499 for serving as a Clinical expert with UK NICE Committee.
Laura M. Tormoehlen, MD, FAAN	The institution of Dr. Tormoehlen has received research support from Genentech. Dr. Tormoehlen has received publishing royalties from a publication relating to health care.
Conrad Weihl, MD, PhD	Dr. Weihl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Dr. Weihl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Casma therapeutics. Dr. Weihl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abata. Dr. Weihl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Weihl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Weihl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acceleron. Dr. Weihl has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Wilson Elser Moskowitz Edelman & Dicker LLP.
Rachel Hunsucker	Ms. Hunsucker has nothing to disclose.
Saketh Annam, MBBS	Dr. Annam has nothing to disclose.
Claude Steriade, MD	The institution of Dr. Steriade has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for The Epilepsy Study Consortium. Dr. Steriade has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Dynamed. Dr. Steriade has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for DOJ. The institution of Dr. Steriade has received research support from NIH. Dr. Steriade has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Epitel. Dr. Steriade has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Jazz Pharmaceuticals.
Stephen G. Reich, MD, FAAN	Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Best Doctors. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UpToDate. Dr. Reich has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Reich has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. The institution of Dr. Reich has received research support from ninds. Dr. Reich has received publishing royalties from a publication relating to health care. Dr. Reich has received publishing royalties from a publication relating to health care.
Jonathan Graff-Radford, MD, FAAN	Dr. Graff-Radford has received personal compensation for serving as an employee of Mayo Clinic. Dr. Graff-Radford has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NINDS/NIH. The institution of Dr. Graff-Radford has received research support from NIH. The institution of Dr. Graff-Radford has received research support from Eisai. The institution of Dr. Graff-Radford has received research support from Cognition therapeutics.
David S. Knopman, MD, FAAN	Dr. Knopman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DIAN TU study. The institution of Dr. Knopman has received research support from NIH.
Zain Guduru, MD, FAAN	Dr. Guduru has nothing to disclose.
Sasha Alick-Lindstrom, MD, FACNS, FAES, FAAN	Dr. Alick-Lindstrom has nothing to disclose.
Teerin Liewluck, MD, FAAN	Dr. Liewluck has nothing to disclose.
Doris G. Leung, MD	The institution of Dr. Leung has received research support from US Department of Defense. The institution of Dr. Leung has received research support from Fulcrum Therapeutics. The institution of Dr. Leung has received research support from ML Bio Solutions, Inc.. The institution of Dr. Leung has received research support from Sarepta Therapeutics. The institution of Dr. Leung has received research support from Cumberland Pharmaceuticals. The institution of Dr. Leung has received research support from FibroGen Inc.. The institution of Dr. Leung has received research support from Astellas Pharma. The institution of Dr. Leung has received research support from University of Kansas Medical Center Research Institute. The institution of Dr. Leung has received research support from Pfizer, Inc.. The institution of Dr. Leung has received research support from Genethon. The institution of Dr. Leung has received research support from Harmony Biosciences. The institution of Dr. Leung has received research support from Edgewise Therapeutics.
Nihal Satyadev, MD, MPH	Mr. Satyadev has nothing to disclose.
Juliette Brenner, MD	Ms. Brenner has nothing to disclose.
Salvatore Mazzeo	Mr. Mazzeo has nothing to disclose.
K. H. Vincent Lau, MD	Dr. Lau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint. The institution of Dr. Lau has received research support from Amyloidosis Foundation.
Ajitesh Ojha, MD	Dr. Ojha has nothing to disclose.
Inbal Maidan, PhD	Dr. Maidan has nothing to disclose.
Melinda Magyari, MD	Dr. Magyari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Magyari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Magyari has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Magyari has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Magyari has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Magyari has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Magyari has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Magyari has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. The institution of Dr. Magyari has received research support from The Danish MS Society. The institution of Dr. Magyari has received research support from Biogen. The institution of Dr. Magyari has received research support from Novartis. The institution of Dr. Magyari has received research support from Roche. The institution of Dr. Magyari has received research support from Merck. The institution of Dr. Magyari has received research support from Sanofi.
Tahseen Mozaffar, MD, FAAN	Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Modis Therapeutics. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB/ Ra Pharmaceuticals. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Maze Therapeutics. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spark Therapeutics. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for National Institutes of Health. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Argenx. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Neuromuscular Disease Foundation. The institution of Dr. Mozaffar has received research support from NIH. The institution of Dr. Mozaffar has received research support from Muscular Dystrophy Association. The institution of Dr. Mozaffar has received research support from Sanofi-Genzyme. The institution of Dr. Mozaffar has received research support from Argenx. The institution of Dr. Mozaffar has received research support from Amicus Therapeutics. The institution of Dr. Mozaffar has received research support from Spark Therapeutics. The institution of Dr. Mozaffar has received research support from Audentes Therapeutics. The institution of Dr. Mozaffar has received research support from Cartesian. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH.
Bradley Lega, MD	The institution of Bradley Lega has received research support from NIH.
Amanda L. Piquet, MD, FAAN	The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. The institution of Dr. Piquet has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. The institution of Dr. Piquet has received personal compensation in the range of $0-$499 for serving as a Consultant for EMD Serono. Dr. Piquet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Piquet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Piquet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. The institution of Dr. Piquet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Sands Anderson PC. Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Joe Jones Law Firm. The institution of Dr. Piquet has received research support from Rocky Mountain MS Center. The institution of Dr. Piquet has received research support from Novartis. The institution of Dr. Piquet has received research support from Abbvie. The institution of Dr. Piquet has received research support from Roche/Genentech. The institution of Dr. Piquet has received research support from NYU. The institution of Dr. Piquet has received research support from Anokion. The institution of Dr. Piquet has received research support from UCB . The institution of Dr. Piquet has received research support from Foundation for Sarcoidosis. Dr. Piquet has received publishing royalties from a publication relating to health care. Dr. Piquet has received publishing royalties from a publication relating to health care. Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as a Litigative Consultant with US-Dept HHS/DICP. Dr. Piquet has a non-compensated relationship as a Medical Advisory Board Member with Autoimmune Encephalitis Alliance (AEA) that is relevant to AAN interests or activities. Dr. Piquet has a non-compensated relationship as a Medical Advisory Board Member with Stiff Person Syndrome Research Foundation (SPSRF) that is relevant to AAN interests or activities.
Nicholas E. Johnson, MD, FAAN	Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta Therapuetics. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne Therapeutics. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex Pharma. Dr. Johnson has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for ML BIo . Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avidity. Dr. Johnson has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Arthex. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Juvena. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Entrada. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rgenta. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Angle Therapeutics. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AskBio. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fulcrum. Dr. Johnson has stock in Angle Therapeutics. Dr. Johnson has stock in Juvena Therapeutics. The institution of Dr. Johnson has received research support from Novartis. The institution of Dr. Johnson has received research support from Takeda . The institution of Dr. Johnson has received research support from AMO Pharma. The institution of Dr. Johnson has received research support from Sarepta. The institution of Dr. Johnson has received research support from Dyne Therapeutics. The institution of Dr. Johnson has received research support from AskBio. The institution of Dr. Johnson has received research support from Pepgen. The institution of Dr. Johnson has received research support from ML Bio. The institution of Dr. Johnson has received research support from Vertex. The institution of Dr. Johnson has received research support from Arthex. Dr. Johnson has received intellectual property interests from a discovery or technology relating to health care.
Neill R. Graff-Radford, MD, FAAN	The institution of Dr. Graff-Radford has received research support from Biogen. The institution of Dr. Graff-Radford has received research support from Lilly. The institution of Dr. Graff-Radford has received research support from Novartis. The institution of Dr. Graff-Radford has received research support from AbbVie. Dr. Graff-Radford has received publishing royalties from a publication relating to health care.
Benjamin R. Kummer, MD	Dr. Kummer has received personal compensation in the range of $0-$499 for serving as a Consultant for Atheneum Partners. Dr. Kummer has received personal compensation in the range of $0-$499 for serving as a Consultant for AlphaSights. Dr. Kummer has received personal compensation in the range of $0-$499 for serving as a Consultant for Gehrson Lehrman Group . Dr. Kummer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Syapse. Dr. Kummer has received personal compensation in the range of $0-$499 for serving as a Consultant for NeuraHealth. Dr. Kummer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Syntrillo. Dr. Kummer has stock in Syntrillo. The institution of Dr. Kummer has received research support from Icahn School of Medicine at Mount Sinai.
David L. Perez, MD, FAAN	Dr. Perez has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley: Brain and Behavior. The institution of Dr. Perez has received research support from NIH. The institution of Dr. Perez has received research support from Sidney R. Baer Jr. Foundation. Dr. Perez has received publishing royalties from a publication relating to health care. Dr. Perez has received publishing royalties from a publication relating to health care.
Jafar Kafaie, MD, PhD	Dr. Kafaie has nothing to disclose.
Annie Z. He	Ms. He has nothing to disclose.
Sol T. De Jesus, MD	Dr. De Jesus has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic Inc.
Amanda L. Porter, MD	Dr. Porter has nothing to disclose.
Lara C. Wadi, MD	Dr. Wadi has nothing to disclose.
Anke Salmen	The institution of Anke Salmen has received research support from Baasch Medicus Foundation. The institution of Anke Salmen has received research support from Swiss MS Society. The institution of Anke Salmen has received research support from Medical Faculty of the University of Bern. Anke Salmen has received personal compensation in the range of $500-$4,999 for serving as a speaker with Bristol Myers Squibb, CSL Behring, Novartis, Roche.
Stephen Wanaski, PhD	Dr. Wanaski has received personal compensation for serving as an employee of Paragon Biosciences. Dr. Wanaski has stock in Paragon Biosciences. Dr. Wanaski has stock in Emalex Biosciences.
Annette Orleth	No disclosure on file
Nikhil Modak, MD	Dr. Modak has nothing to disclose.
Abbey Staugaitis	No disclosure on file
Vineet Punia, MD	Dr. Punia has nothing to disclose.
Cody L. Nathan, MD	Dr. Nathan has nothing to disclose.
Ludy C. Shih, MD, FAAN	Dr. Shih has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Encora Therapeutics. Dr. Shih has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus. Dr. Shih has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for WCG Medavante. Dr. Shih has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Shih has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley . The institution of Dr. Shih has received research support from Abbott. The institution of Dr. Shih has received research support from Praxis Precision Medicines. The institution of Dr. Shih has received research support from Tremor Research Group. Dr. Shih has received personal compensation in the range of $500-$4,999 for serving as a Consultant with German Accelerator. Dr. Shih has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with National Institutes of Health. Dr. Shih has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with Michael J. Fox Foundation. Dr. Shih has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with Johns Hopkins.
Ritesh Ramdhani, MD	Dr. Ramdhani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Accorda. Dr. Ramdhani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amneal. The institution of Dr. Ramdhani has received research support from NIH. Dr. Ramdhani has received research support from Parkinson Alliance.
Xiaolan Zhang, Other	Mrs. Zhang has nothing to disclose.
Virend Somers	No disclosure on file
Vanessa Salasky, MD	Dr. Salasky has nothing to disclose.
Blanca R. Vazquez, MD	Dr. Vazquez has nothing to disclose.
Tomas Kalincik	Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi Genzyme. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving as a Consultant for National Health and Medical Research Council. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MS Research Australia. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for WebMD Global. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi Genzyme. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for BioCSL. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merck. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. The institution of Tomas Kalincik has received research support from Biogen. The institution of Tomas Kalincik has received research support from Novartis. The institution of Tomas Kalincik has received research support from Genzyme. The institution of Tomas Kalincik has received research support from Roche. The institution of Tomas Kalincik has received research support from Celgene. The institution of Tomas Kalincik has received research support from Merck. The institution of Tomas Kalincik has received research support from MSBase Foundation. The institution of Tomas Kalincik has received research support from ARSEP and EDMUS Foundations. The institution of Tomas Kalincik has received research support from MS Research Australia. The institution of Tomas Kalincik has received research support from National Health and Medical Research Council. The institution of Tomas Kalincik has received research support from Australian Research Council. The institution of Tomas Kalincik has received research support from MS Society. The institution of Tomas Kalincik has received research support from Trish Foundation. Tomas Kalincik has a non-compensated relationship as a scientific leadership group vice-chair with MSBase Foundation that is relevant to AAN interests or activities.
Danielle M. Howard, MD	The institution of Dr. Howard has received research support from Genentech. The institution of Dr. Howard has received research support from Novartis. Dr. Howard has received personal compensation in the range of $50,000-$99,999 for serving as a Clinical Fellow with National Multiple Sclerosis Society.
Kelly D. Foote, MD	Kelly D. Foote, MD has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axio/Neurocrine Biosciences.
Roohi Katyal, MD	Dr. Katyal has nothing to disclose.
Alexander M. Papanastassiou	Alexander M. Papanastassiou has received intellectual property interests from a discovery or technology relating to health care.
Yadi Li	No disclosure on file
Giulia Giacomucci, MD	Ms. Giacomucci has nothing to disclose.
Igal Mirman, MD	Dr. Mirman has nothing to disclose.
Enrique Carrazana	Enrique Carrazana has received personal compensation for serving as an employee of Neurelis. Enrique Carrazana has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Hawaii-Biotech, CND Life Sciences, Apex Labs. Enrique Carrazana has stock in Neurelis, CND, Apex.
Sima I. Patel, MD	Dr. Patel has nothing to disclose.
Elina Zakin, MD	The institution of Dr. Zakin has received research support from American Board of Psychiatry and Neurology.
Russell Grant	No disclosure on file
Priya Nidamanuri, MD	Dr. Nidamanuri has nothing to disclose.
Rachel Galioto	Rachel Galioto has nothing to disclose.
Kemi Bankole, MBBS	Dr. Bankole has received personal compensation for serving as an employee of Sage Therapeutics. Dr. Bankole has stock in Sage Therapeutics.
Masako Matsunaga	No disclosure on file
Ahmad Sawalha, MD	Dr. Sawalha has nothing to disclose.
J. H. Harvey, DO	Dr. Harvey has received personal compensation for serving as an employee of RSC Diagnostics. The institution of Dr. Harvey has received research support from GW Pharmaceuticals. The institution of Dr. Harvey has received research support from Cerevel Pharmaceuticals. The institution of Dr. Harvey has received research support from UCB Pharmaceuticals.
Yonas E. Geda, MD	The institution of Dr. Geda has received research support from NIH.
Kathryn Eszes, MD	Dr. Eszes has nothing to disclose.
Jennifer M. Martinez-Thompson, MD	Dr. Martinez-Thompson has nothing to disclose.
Sabrina Bulancea	Sabrina Bulancea has nothing to disclose.
Mary Clare McKenna, MB BCh BAO PhD	Dr. McKenna has nothing to disclose.
Ryan Kammeyer, MD	Dr. Kammeyer has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Ogborn-Mihm Trial Lawyers. The institution of Dr. Kammeyer has received research support from Rocky Mountain Multiple Sclerosis Center.
Anna Bastiaansen	Anna Bastiaansen has nothing to disclose.
Peter B. Kang, MD, FAAN	Dr. Kang has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Kang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sarepta Therapeutics. Dr. Kang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Kang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NS Pharma. Dr. Kang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teneofour. Dr. Kang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lupin. Dr. Kang has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. The institution of Dr. Kang has received research support from Xtraordinary Joy Foundation. The institution of an immediate family member of Dr. Kang has received research support from Sarepta Therapeutics. The institution of Dr. Kang has received research support from Centers for Disease Control and Prevention (CDC). The institution of Dr. Kang has received research support from National Institutes of Health (NIH). The institution of Dr. Kang has received research support from Food and Drug Administration. The institution of Dr. Kang has received research support from National Initiative for Cockayne Syndrome. The institution of Dr. Kang has received research support from Greg Marzolf Jr Foundation. An immediate family member of Dr. Kang has received intellectual property interests from a discovery or technology relating to health care. Dr. Kang has received publishing royalties from a publication relating to health care. Dr. Kang has received personal compensation in the range of $5,000-$9,999 for serving as a Medical Advisory Board with National Initiative for Cockayne Syndrome. Dr. Kang has a non-compensated relationship as a Medical Advisory Board with Speak Foundation that is relevant to AAN interests or activities. Dr. Kang has a non-compensated relationship as a TRIAD Council with Hereditary Neuropathy Foundation that is relevant to AAN interests or activities. Dr. Kang has a non-compensated relationship as a President with Child Neurology Society that is relevant to AAN interests or activities. Dr. Kang has a non-compensated relationship as a Board Member with Child Neurology Foundation that is relevant to AAN interests or activities.
Daniel J. Correa, MD, MSc, FAAN	Dr. Correa has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. Dr. Correa has stock in Aidin Inc. Dr. Correa has received research support from Genentech. Dr. Correa has received research support from Psi Upsilon Foundation Inc.
Breanna Chachere	Ms. Chachere has nothing to disclose.
Kan Ding, MD	The institution of Dr. Ding has received research support from National Institute of Aging. The institution of Dr. Ding has received research support from NINDS.
Tejdip Singh	Tejdip Singh has received personal compensation for serving as an employee of Sarepta Therapeutics . Tejdip Singh has received stock or an ownership interest from Sarepta Therapeutics.
Annalisa Morgan, MD	Dr. Morgan has nothing to disclose.
Enric Monreal Laguillo	Enric Monreal Laguillo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Enric Monreal Laguillo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Enric Monreal Laguillo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Enric Monreal Laguillo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Enric Monreal Laguillo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol-Myers Squibb. Enric Monreal Laguillo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Enric Monreal Laguillo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Enric Monreal Laguillo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Enric Monreal Laguillo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Enric Monreal Laguillo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Enric Monreal Laguillo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol-Myers Squibb.
Apirada Thongsing, MD	Dr. Thongsing has nothing to disclose.
Stefanie Mason, MD	Dr. Mason has received personal compensation for serving as an employee of Sarepta. Dr. Mason has stock in Sarepta. An immediate family member of Dr. Mason has stock in Sarepta. The institution of an immediate family member of Dr. Mason has received research support from Biogen. The institution of Dr. Mason has received research support from NIH. The institution of Dr. Mason has received research support from Chest Foundation.
Florencia Daniele	No disclosure on file
Claudio Gobbi, MD	The institution of Dr. Gobbi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie, Almirall, Biogen Idec, Celgene, Sanofi, Merck, Novartis, Teva Pharma, Roche.. Dr. Gobbi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie, Almirall, Biogen Idec, Celgene, Sanofi, Merck, Novartis, Teva Pharma, Roche..
Clary B. Clish	No disclosure on file
Sergio Muniz-Castrillo, MD, PhD	Dr. Muniz-Castrillo has nothing to disclose.
Sabine Schaedelin	No disclosure on file
Lindsay N. Alfano, PT	Ms. Alfano has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ATOM International, Ltd (Amicus Therapeutics, Catabasis, Genethon, Italfarmaco, NS Pharma, Pfizer, PTC Therapeutics). Ms. Alfano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta Therapeutics. The institution of Ms. Alfano has received research support from Novartis Gene Therapies. The institution of Ms. Alfano has received research support from Sarepta Therapeutics. The institution of Ms. Alfano has received research support from Audentes Therapeutics/Astellas Gene Therapies. Ms. Alfano has received intellectual property interests from a discovery or technology relating to health care.
Melanie Braun, MD	Dr. Braun has nothing to disclose.
Evelyn Lazar, MD	Dr. Lazar has nothing to disclose.
Mohammad Abughanam, MD	Dr. Abughanam has nothing to disclose.
Qutubuddin G. Khan, MBBS	No disclosure on file
Matthew P. Wicklund, MD, FAAN	Dr. Wicklund has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus Therapeutics. Dr. Wicklund has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. Dr. Wicklund has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta Therapeutics. Dr. Wicklund has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Spark Therapeutics. Dr. Wicklund has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ultragenyx. Dr. Wicklund has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vertex Pharmaceuticals. The institution of Dr. Wicklund has received research support from Orphazyme. The institution of Dr. Wicklund has received research support from Muscular Dystrophy Association. The institution of Dr. Wicklund has received research support from Coalition to Cure Calpain 3. The institution of Dr. Wicklund has received research support from Sarepta Therapeutics. The institution of Dr. Wicklund has received research support from ML Bio. The institution of Dr. Wicklund has received research support from Alexion. The institution of Dr. Wicklund has received research support from Acceleron. The institution of Dr. Wicklund has received research support from Edgewise. The institution of Dr. Wicklund has received research support from Fulcrum. The institution of Dr. Wicklund has received research support from Roche-Genentech. The institution of Dr. Wicklund has received research support from Avidity. Dr. Wicklund has received research support from Harmony Bioscience.
Aidan Power, PhD	Dr. Power has received personal compensation for serving as an employee of Alzheon. Dr. Power has stock in Pfizer. Dr. Power has stock in Alzheon.
Christopher J. Klein, MD, FAAN	Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo Therapeutics . Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Faze Medicine .
Ailing E. Yang, MD	Dr. Yang has nothing to disclose.
Maria Vassilaki, MD, PhD	The institution of Dr. Vassilaki has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for F. Hoffmann-La Roche Ltd . Dr. Vassilaki has stock in Abbott Laboratories. Dr. Vassilaki has stock in Johnson and Johnson. Dr. Vassilaki has stock in Medtronic. Dr. Vassilaki has stock in Amgen. Dr. Vassilaki has stock in AbbVie. Dr. Vassilaki has stock in Merck. The institution of Dr. Vassilaki has received research support from NIH. The institution of Dr. Vassilaki has received research support from European Union/ St. Anne's University Hospital Brno, Czech Republic. The institution of an immediate family member of Dr. Vassilaki has received research support from Avobis Bio, LLC.
Marina Sarno, Other	Dr. Sarno has nothing to disclose.
Simon Thebault, MD	Dr. Thebault has nothing to disclose.
Juna De Vries	Juna De Vries has nothing to disclose.
Jed Black, MD	Jed Black, MD has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Jed Black, MD has stock in Jazz Pharmaceuticals. Jed Black, MD has stock in .
Sean Selva	No disclosure on file
Maarten J. Titulaer, MD, PhD	The institution of Dr. Titulaer has received research support from Dutch Epilepsy Foundations (NEF 19-08). The institution of Dr. Titulaer has received research support from CSL Behring. The institution of Dr. Titulaer has received research support from UCB. The institution of Dr. Titulaer has received research support from Netherlands Organisation for Scientific Research (ZonMW, Memorabel initiative and E-RARE UltraAIE) . The institution of Dr. Titulaer has received research support from Horizon Therapeutics / Amgen. The institution of Dr. Titulaer has received research support from Dioraphte (charity). The institution of Dr. Titulaer has received research support from Guidepoint Global LLC. The institution of Dr. Titulaer has received research support from ArgenX. Dr. Titulaer has received publishing royalties from a publication relating to health care.
Can Ebru Kurt, MD	Can Ebru Kurt, MD has nothing to disclose.
Zeba Noorain, MBBS	Dr. Noorain has nothing to disclose.
Nada Ahmed, MD	Dr. Ahmed has nothing to disclose.
Bishow Chandra Mahat, MD	Dr. Mahat has nothing to disclose.
Jeffrey L. Cummings, MD, FAAN	Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ACADIA. Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alkahest. Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche/Genentech. Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Green Valley. Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Otsuaka. Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving as a Consultant for United Neuroscience. Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Cummings has received research support from NIH. Dr. Cummings has received intellectual property interests from a discovery or technology relating to health care.
Monica Buckley, MD, PhD	Dr. Buckley has nothing to disclose.
Sanem P. Uysal, MD	Dr. Uysal has nothing to disclose.
Veronica A. Tkachuk	Veronica A. Tkachuk has nothing to disclose.
Maria Campo Amigo	Maria Campo Amigo has nothing to disclose.
Maria Florendo, MD	Dr. Florendo has nothing to disclose.
Kassandra L. Munger	Ms. Munger has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Ms. Munger has received research support from Department of Defense.
Doris Xia, DO	Dr. Xia has nothing to disclose.
Ana Belen Caminero Rodriguez, MD	Dr. Caminero Rodriguez has nothing to disclose.
Shrikant Mishra, MD	Dr. Mishra has nothing to disclose.
Josep O. Dalmau, MD, PhD, FAAN	Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas Research Institute of America. Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Research & Development . Dr. Dalmau has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. An immediate family member of Dr. Dalmau has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Dalmau has received research support from Sage Therapeutics. The institution of Dr. Dalmau has received research support from Edmond J.Safra Foundation . The institution of Dr. Dalmau has received research support from La Caixa Foundation. The institution of Dr. Dalmau has received research support from Spanish Ministry of Health (ISCIII). The institution of Dr. Dalmau has received research support from Euroimmun, Inc. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care.
Divyanshu Dubey, MD, FAAN	The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from UCB. Dr. Dubey has received research support from David J. Tomassoni ALS Research Grant Program . Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care.
Doris Kung, DO, FAAN	Dr. Kung has received personal compensation for serving as an employee of Aquifer. The institution of Dr. Kung has received research support from RxFunction. Dr. Kung has received publishing royalties from a publication relating to health care. Dr. Kung has received personal compensation in the range of $0-$499 for serving as a Workgroup member with NBME. Dr. Kung has received personal compensation in the range of $500-$4,999 for serving as a Editor with Aquifer.
Ihtsham Haq, MD, FAAN	The institution of Dr. Haq has received research support from NINDS. The institution of Dr. Haq has received research support from the Parkinson's Foundation. The institution of Dr. Haq has received research support from NIMH.
Karima Benameur, MD	Dr. Benameur has nothing to disclose.
Nancy R. Foldvary-Schaefer, DO, FAAN	Dr. Foldvary-Schaefer has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz. The institution of Dr. Foldvary-Schaefer has received research support from Jazz. The institution of Dr. Foldvary-Schaefer has received research support from Suven. The institution of Dr. Foldvary-Schaefer has received research support from Takeda. Dr. Foldvary-Schaefer has received publishing royalties from a publication relating to health care. Dr. Foldvary-Schaefer has received publishing royalties from a publication relating to health care.
Marisa P. McGinley, DO	Dr. McGinley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave. Dr. McGinley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. McGinley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. The institution of Dr. McGinley has received research support from Novartis. The institution of Dr. McGinley has received research support from Biogen. The institution of Dr. McGinley has received research support from Genentech. The institution of Dr. McGinley has received research support from NIH.
Mark S. Freedman, MD, FAAN	Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Actelion(Janssen/J&J). Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BiogenIdec. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS/Celgene. Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Inc. Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion (Janssen/J&J). Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Atara Biotherapeutics. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer Healthcare. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for BiogenIdec. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Clene Nanomedicine. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GRI Bio. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Magenta Therapeutics. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Freedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi Genzyme. Dr. Freedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. The institution of Dr. Freedman has received research support from Sanofi Genzyme.
Philip W. Tipton, MD	Dr. Tipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Tipton has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Alzheimer's Tennessee. Dr. Tipton has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Charlotte County Medical Society, Inc.
Neishay Ayub, MD	The institution of Dr. Ayub has received research support from Brown Physicians Incorporated. The institution of Dr. Ayub has received research support from Pappitto Opportunity Connection.
Toni Pearson, MBBS	Dr. Pearson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva Pharmaceuticals. The institution of Dr. Pearson has received research support from NIH.
Ajay K. Misra, MD	Dr. Misra has nothing to disclose.
Shweta Kalita	Mrs. Kalita has nothing to disclose.
Rodrigo Zepeda, MD	The institution of Dr. Zepeda Garcia has received research support from NIH.
Jorge Maurino	Jorge Maurino has received personal compensation for serving as an employee of Roche Pharma Spain, Medical Department.
Anastasia Vishnevetsky, MD	The institution of Dr. Vishnevetsky has received research support from National MS Society. The institution of Dr. Vishnevetsky has received research support from NIH (NeuroNext).
Cong Zhi Zhao, MD	Dr. Zhao has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Efficient CME. Dr. Zhao has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva.
Sari Atula, MD, PhD	Sari Atula, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Sari Atula, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Sari Atula, MD, PhD has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Sari Atula, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Sari Atula, MD, PhD has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen.
Lei Liu, MD, PhD	Dr. Liu has nothing to disclose.
Umar Yazdani	Mr. Yazdani has nothing to disclose.
Fernando Cendes, MD, PhD, FAAN	Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Biopharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for United Medical – Brazil. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zodiac Pharma . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eurofarma – Brazil . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology - Epilepsy. The institution of Dr. Cendes has received research support from São Paulo Research Foundation - FAPESP. The institution of Dr. Cendes has received research support from Conselho Nacional de Desenvolvimento Científico e Tecnológico - Brazil . The institution of Dr. Cendes has received research support from NIH.
Nadir Abdelrahman	No disclosure on file
Peter Sillevis Smitt, MD	The institution of Dr. Sillevis Smitt has received research support from Euroimmun. Dr. Sillevis Smitt has received intellectual property interests from a discovery or technology relating to health care.
Pierre Tariot	Pierre Tariot has received personal compensation for serving as an employee of Banner Alzheimer's Institute. Pierre Tariot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Pierre Tariot has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AC Immune. Pierre Tariot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Pierre Tariot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for WebMD. Pierre Tariot has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arcadia. Pierre Tariot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Pierre Tariot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BioXcel. Pierre Tariot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cortexyme. Pierre Tariot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Pierre Tariot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for eNOVA. Pierre Tariot has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Pierre Tariot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos. Pierre Tariot has received intellectual property interests from a discovery or technology relating to health care.
Jenny Linnoila, MD, PhD	Dr. Linnoila has received research support from NIH/NINDS. Dr. Linnoila has received personal compensation in the range of $10,000-$49,999 for serving as a expert respondent on autoimmune encephalitis with U.S. government/DHHS/vaccine injury compensation program.
Amit Bar-Or, MD, FRCPC	Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen/Actelion. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atara Biotherapeutics. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merk/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Atara Biotherapeutics. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. The institution of Dr. Bar-Or has received research support from Novartis. The institution of Dr. Bar-Or has received research support from Biogen. The institution of Dr. Bar-Or has received research support from Roche/Genentech. The institution of Dr. Bar-Or has received research support from Merck/EMD Serono.
Elena Natera-Villalba, MD	Mrs. NATERA-VILLALBA has received research support from Sociedad Española de Neurologia.
Edgar Carnero Contentti	Edgar Carnero Contentti has nothing to disclose.
Christine Cliatt Brown, MD	Dr. Cliatt Brown has nothing to disclose.
Rosalind Mandelbaum, PA	No disclosure on file
Jeffrey Statland, MD	Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arrowhead. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ML Bio. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MT Pharma. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Epic Bio. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Armatus . Dr. Statland has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dyne Therapeutics. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity . Dr. Statland has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fulcrum Therapeutics. Dr. Statland has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Statland has received research support from NIH. The institution of Dr. Statland has received research support from FSHD Society. The institution of Dr. Statland has received research support from Friends of FSH Research. The institution of Dr. Statland has received research support from FSHD Canada. The institution of Dr. Statland has received research support from MDA.
Leorah A. Freeman, MD, PhD	Dr. Freeman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Freeman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffman La-Roche. Dr. Freeman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech, Inc. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Freeman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Freeman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Freeman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Dr. Freeman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Texas Neurological Society. Dr. Freeman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for WebMD. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for MSAA. The institution of Dr. Freeman has received research support from Genentech. The institution of Dr. Freeman has received research support from NIH/NINDS. The institution of Dr. Freeman has received research support from NIH/NINDS. The institution of Dr. Freeman has received research support from PCORI. The institution of Dr. Freeman has received research support from EMD Serono. Dr. Freeman has received personal compensation in the range of $500-$4,999 for serving as a Participant in educational interview with Multiple Sclerosis Association of America.
Ersin Tan, MD	Dr. Tan has nothing to disclose.
Clifford R. Jack, Jr., MD	The institution of Dr. Jack has received research support from NIH. The institution of Dr. Jack has received research support from Alexander Family Alzheimer's Disease Research Professorship of the Mayo Clinic.
John Vissing, MD	Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne Therapeutics. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Solid Biosciences. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus therapeutics. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AskBio. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avidity Therapeutics. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Italfarmaco. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Biopharma. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Johnson & Johnson (Janssen). Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Edgewise Therapeutics. The institution of Prof. Vissing has received research support from Rigshospitalet. The institution of Prof. Vissing has received research support from UCB Pharma. The institution of Prof. Vissing has received research support from Sanofi. The institution of Prof. Vissing has received research support from Roche. The institution of Prof. Vissing has received research support from AnJii.
Justin Abbatemarco, MD	Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech . Dr. Abbatemarco has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics, Inc.. The institution of Dr. Abbatemarco has received research support from Horizon.
Elizabeth M. Berry-Kravis, MD, PhD	The institution of Dr. Berry-Kravis has received research support from NIH. The institution of Dr. Berry-Kravis has received research support from Ionis. The institution of Dr. Berry-Kravis has received research support from Zynerba. The institution of Dr. Berry-Kravis has received research support from Roche. The institution of Dr. Berry-Kravis has received research support from CDC. The institution of Dr. Berry-Kravis has received research support from FRAXA Research Foundation. The institution of Dr. Berry-Kravis has received research support from GeneTx. The institution of Dr. Berry-Kravis has received research support from Angelman Syndrome Foundation. The institution of Dr. Berry-Kravis has received research support from Acadia. The institution of Dr. Berry-Kravis has received research support from Ultragenyx. The institution of Dr. Berry-Kravis has received research support from Mallinckrodt. The institution of Dr. Berry-Kravis has received research support from Together Strong Foundation. The institution of Dr. Berry-Kravis has received research support from Zevra. The institution of Dr. Berry-Kravis has received research support from Taysha. The institution of Dr. Berry-Kravis has received research support from Tetra. The institution of Dr. Berry-Kravis has received research support from Neuren.
Madison Pilato, MD	Dr. Pilato has nothing to disclose.
David W. Loring, PhD, FAAN	Dr. Loring has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. Dr. Loring has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ILAE. The institution of Dr. Loring has received research support from NIH. Dr. Loring has received publishing royalties from a publication relating to health care.
Jong Rho	No disclosure on file
Tobias Derfuss	An immediate family member of Tobias Derfuss has received personal compensation for serving as an employee of Novartis. The institution of Tobias Derfuss has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Tobias Derfuss has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. The institution of Tobias Derfuss has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. The institution of Tobias Derfuss has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. The institution of Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. The institution of Tobias Derfuss has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GeNeuro. Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MedDay. Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion. Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Merck. Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Roche. An immediate family member of Tobias Derfuss has received stock or an ownership interest from Novartis. The institution of Tobias Derfuss has received research support from Roche. The institution of Tobias Derfuss has received research support from Biogen.
Jennifer L. Durphy, MD	Dr. Durphy has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Acorda.
Katharine Dermigny, MD	Dr. Dermigny has nothing to disclose.
Yuka Martens	No disclosure on file
Su Htet Htet Naing, MD	Ms. Naing has nothing to disclose.
Naoki Yamahara, MD	Dr. Yamahara has nothing to disclose.
Solmaz Ramezani Hashtjin, MD	Dr. Ramezani Hashtjin has nothing to disclose.
Christopher Schwarz	The institution of Christopher Schwarz has received research support from NIH.
Roland Dominic Jamora	Roland Dominic Jamora has received personal compensation in the range of $500-$4,999 for serving as a Consultant for torrent. Roland Dominic Jamora has received research support from CCXDP.
Jonadab Dos Santos Silva	Mr. Dos Santos Silva has nothing to disclose.
Joost Kools, MD	The institution of Mr. Kools has received research support from Fulcrum Therapeutics.
Olajide Abiola, MD	Dr. Abiola has nothing to disclose.
Michael D. Geschwind, MD, PhD, FAAN	Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Brainstorm Cell Therapeutics, Inc.. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Walter Grubb. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lehrman Group. Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Reata Pharmaceuticals, Inc..
Margherita Milone, MD, FAAN	Dr. Milone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Milone has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Genetics, AAN. The institution of Dr. Milone has received research support from Mayo Clinic, CCaTS-CBD. The institution of Dr. Milone has received research support from Mayo Clinic, SGP Award. The institution of Dr. Milone has received research support from MDA for Care Center grant. The institution of Dr. Milone has received research support from Regenerative medicine Minnesota.
Stephan Schuele, MD, FAAN	Dr. Schuele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Monteris. Dr. Schuele has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurelis. Dr. Schuele has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Science. Dr. Schuele has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jazz. Dr. Schuele has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neurophysiology. Dr. Schuele has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Thomas Needham. Dr. Schuele has received research support from National Institute of Health.
Adrian Budhram, MD	Dr. Budhram has nothing to disclose.
Raffaella Umeton, MD, PhD, MMSc	Dr. Umeton has nothing to disclose.
Cynthia E. Armand, MD	Dr. Armand has received personal compensation in the range of $0-$499 for serving as a Consultant for Abbvie. Dr. Armand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. Dr. Armand has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Spire Learning. Dr. Armand has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology.
Maria Agustina Ruiz Yanzi, MD	Dr. Ruiz Yanzi has nothing to disclose.
Jordan S. Dubow, MD	Dr. Dubow has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Avadel Pharmaceuticals.
Aristide Merola, MD, PhD	Dr. Merola has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Merola has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbott. Dr. Merola has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology.
Amanda Puckett	Miss Puckett has nothing to disclose.
Kalina Misiolek, MD	Dr. Misiolek has nothing to disclose.
Jeremiah Aakre	No disclosure on file
Laura Borrega Canelo	No disclosure on file
Jonathan Gursky, MD	Dr. Gursky has nothing to disclose.
Simona Treidler, MD	Dr. Treidler has nothing to disclose.
Mariann Polgar-Turcsanyi	No disclosure on file
Panagiotis Kassavetis, MD	Dr. Kassavetis has nothing to disclose.
Zhi-Jian Chen, MD	Dr. Chen has nothing to disclose.
Derek Martinez	No disclosure on file
Christopher R. Barton, MD	Dr. Barton has nothing to disclose.
Takayoshi Shimohata, MD, FAAN	Dr. Shimohata has nothing to disclose.
Anam Syed, DO	Dr. Syed has nothing to disclose.
Rozaleen Aleyadeh, MD	Dr. Aleyadeh has nothing to disclose.
Leah Blank, MD	The institution of an immediate family member of Dr. Blank has received personal compensation in the range of $0-$499 for serving as a Consultant for Bristol Myers Squibb (Legal). The institution of Dr. Blank has received research support from American Epilepsy Foundation/Epilepsy Foundation/NORSE Foundation. The institution of Dr. Blank has received research support from NIA (Mount Sinai OAIC).
Luis Rafael Solís-Tarazona, MD	Mr. Solís-Tarazona has received personal compensation for serving as an employee of Novo Nordisk A/S.
Hrishikesh A. Lokhande	Mr. Lokhande has nothing to disclose.
Mark Agostini, MD	Dr. Agostini has nothing to disclose.
Fernando J. Caceres, MD	No disclosure on file
Solomon L. Moshe, MD, FAAN	Dr. Moshe has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink. Dr. Moshe has received publishing royalties from a publication relating to health care. Dr. Moshe has received personal compensation in the range of $500-$4,999 for serving as a Reviewer of study sections with NINDS.
Erika B. Chandler, MD	Dr. Chandler has nothing to disclose.
Jay Panicker, MD, MBBS, Other	Dr. Panicker has nothing to disclose.
Clarissa L. Yasuda, MD, PhD	Prof. Yasuda has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for LIBBS. Prof. Yasuda has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABBOTT. Prof. Yasuda has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for LIBBS.
Sama Noroozi Gilandehi, MD	Dr. Noroozi Gilandehi has nothing to disclose.
Kerry H. Levin, MD, FAAN	Dr. Levin has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwer. Dr. Levin has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Levin has received publishing royalties from a publication relating to health care. Dr. Levin has received publishing royalties from a publication relating to health care.
Christopher Anderson, MD	Dr. Anderson has nothing to disclose.
Merce Boada Rovira, MD, PhD	Dr. Boada Rovira has received personal compensation for serving as an employee of FUNDACIO ACE. ICNA. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GRIFOLS. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ARACLON BIOTECH. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ROCHE. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BIOGEN. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MERCK. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ZAMBON. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GRIFOLS. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ARACLON BIOTECH. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOGEN. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for LILLY. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MERCK. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ZAMBON. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NOVO NORDISK. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOIBERICA. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SERVIER. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EISAI. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SCHWABE PHARMA. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ROCHE. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BIOGEN. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for GRIFOLS. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for NUTRICIA. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ARACLON BIOTECH. The institution of Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SERVIER. Dr. Boada Rovira has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for ZAMBON.
Alan R. Hirsch, MD, FACP	Dr. Hirsch has nothing to disclose.
Tzu-ying Chuang, MD, PhD	Dr. Chuang has nothing to disclose.
Ashlynn Mills	Mrs. Mills has nothing to disclose.
Eline Willemse	No disclosure on file
Lisa E. Farnett	Ms. Farnett has received personal compensation for serving as an employee of Sanofi. Ms. Farnett has stock in Sanofi.
Elizabeth Gerard, MD	Dr. Gerard has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Greenwich Pharmaceuticals. The institution of Dr. Gerard has received research support from NIH/NINDS. The institution of Dr. Gerard has received research support from Xenon Pharmaceuticals. The institution of an immediate family member of Dr. Gerard has received research support from NIH. The institution of an immediate family member of Dr. Gerard has received research support from Novo Nordisk. The institution of Dr. Gerard has received research support from Eisai, Inc. (via Stanford University).
DonRaphael P. Wynn, MD	Dr. Wynn has nothing to disclose.
Michael Khalil	Michael Khalil has nothing to disclose.
Michael A. Witt, MD	Dr. Witt has nothing to disclose.
Peter Hedera, MD	Dr. Hedera has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Hedera has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Hedera has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for University of Louisville.
Makoto Yoneda	The institution of Makoto Yoneda has received research support from Cosmic Corporation.
Howard L. Weiner, MD	Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tiziana Life Sciences. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for vTv Therapeutics. Dr. Weiner has stock in vTv Therapeutics. The institution of Dr. Weiner has received research support from National Institute of Health. The institution of Dr. Weiner has received research support from National MS Society. The institution of Dr. Weiner has received research support from Genzyme Corp. The institution of Dr. Weiner has received research support from Genentech, Inc. . The institution of Dr. Weiner has received research support from Verily Life Sciences LLC. The institution of Dr. Weiner has received research support from EMD Serono, Inc..
Ana M. Alonso Torres, MD	Dr. Alonso Torres has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Alonso Torres has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Alonso Torres has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Hesham A. Abboud, MD	Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech . Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alpine Pharma. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cycle Pharma. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axonics. Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion . Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Horizon. The institution of Dr. Abboud has received research support from Genentech . The institution of Dr. Abboud has received research support from Novartis. The institution of Dr. Abboud has received research support from BMS. The institution of Dr. Abboud has received research support from Sanofi-Genzyme. The institution of Dr. Abboud has received research support from The Guthy-Jackson Charitable Foundation. Dr. Abboud has received publishing royalties from a publication relating to health care.
Bob Bucelli, MD, PhD	Dr. Bucelli has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen . Dr. Bucelli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Bucelli has stock in Neuroquestions.com. An immediate family member of Dr. Bucelli has stock in Neuroquestions.com. The institution of Dr. Bucelli has received research support from Biogen. The institution of Dr. Bucelli has received research support from Ionis.
Abdolreza Siadati	No disclosure on file
Rebekah L. Summers, PhD, PT	Rebekah Summers has received personal compensation for serving as an employee of Medtronic. Rebekah Summers has received research support from National Institute of Health.
Sean B. Woods	Mr. Woods has nothing to disclose.
Nathan Morelli, PhD, PT	Dr. Morelli has received personal compensation for serving as an employee of Medtronic.
Roshini Jain	Roshini Jain has received personal compensation for serving as an employee of Boston Scientific. Roshini Jain has received stock or an ownership interest from Boston Scientific.
Muhammad Bilal Tariq, MBBS	Dr. Tariq has nothing to disclose.
Frank Leypoldt, MD	Frank Leypoldt, MD has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Frank Leypoldt, MD has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argen. The institution of Frank Leypoldt, MD has received research support from German Ministry of Research BMBF.
Keisuke Ueda, MD	Dr. Ueda has nothing to disclose.
Michael S. Okun, MD, FAAN	Dr. Okun has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Okun has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Parkinson's Foundation. Dr. Okun has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Okun has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Journal Watch. The institution of Dr. Okun has received research support from NIH. The institution of Dr. Okun has received research support from Parkinson's Foundation. The institution of Dr. Okun has received research support from Tourette Association of America. The institution of Dr. Okun has received research support from Michael J Fox. Dr. Okun has received publishing royalties from a publication relating to health care.
Ludwig Kappos, MD, FAAN	The institution of Dr. Kappos has received research support from Bayer. The institution of Dr. Kappos has received research support from Biogen. The institution of Dr. Kappos has received research support from Genentech. The institution of Dr. Kappos has received research support from Genzyme. The institution of Dr. Kappos has received research support from Janssen. The institution of Dr. Kappos has received research support from Merck Serono. The institution of Dr. Kappos has received research support from Minoryx. The institution of Dr. Kappos has received research support from Novartis. The institution of Dr. Kappos has received research support from Roche. The institution of Dr. Kappos has received research support from Sanofi. The institution of Dr. Kappos has received research support from Santhera. The institution of Dr. Kappos has received research support from Swiss MS Society, Swiss National Research Foundation, European Union, Roche Research Foundation, Innosuisse. The institution of Dr. Kappos has received research support from Shionogi. The institution of Dr. Kappos has received research support from Japan Tobacco. The institution of Dr. Kappos has received research support from Auriga Vision AG. The institution of Dr. Kappos has received research support from EMD Serono. The institution of Dr. Kappos has received research support from Glaxo Smith Kline. The institution of Dr. Kappos has received research support from Wellmera AG. The institution of Dr. Kappos has received research support from Eli Lilly (Suisse) SA. The institution of Dr. Kappos has received research support from Bristol Myers Squibb. The institution of Dr. Kappos has received research support from Celltrion Inc. Dr. Kappos has received intellectual property interests from a discovery or technology relating to health care.
Yasodara Priyadharsi Senthamarai Siddharthan, MBBS	Dr. Senthamarai Siddharthan has nothing to disclose.
Theresa A. Zesiewicz, MD	Dr. Zesiewicz has received personal compensation for serving as an employee of Medscape. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care.
Meagen Salinas, MD	The institution of Dr. Salinas has received research support from North Texas VA Health Care System New Investigator Award.
Lawrence Steinman, MD, FAAN	Dr. Steinman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for 180 Life Sciences. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for BioAtla. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Pasithea. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Atreca. Dr. Steinman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Steinman has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for National Academy of Sciences. Dr. Steinman has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Gibson Dunn. The institution of Dr. Steinman has received research support from Roche. The institution of Dr. Steinman has received research support from Novartis. Dr. Steinman has received intellectual property interests from a discovery or technology relating to health care.
Muhammad I. Yousaf, MD	Dr. Yousaf has nothing to disclose.
Taylor J. Saraceno	Ms. Saraceno has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cumming Foundation. The institution of Ms. Saraceno has received research support from I-Mab Biopharma.
Chiara C. Zecca, MD	The institution of Dr. Zecca has received research support from Ente Ospedaliero Cantonale.
Jumana T. Alshaikh, MD	Dr. Alshaikh has nothing to disclose.
Bjorn E. Oskarsson, MD, FAAN	Dr. Oskarsson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. The institution of Dr. Oskarsson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Oskarsson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AnnJi. The institution of Dr. Oskarsson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi. Dr. Oskarsson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Tsumura. The institution of Dr. Oskarsson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MediciNova. The institution of Dr. Oskarsson has received research support from Biogen. The institution of Dr. Oskarsson has received research support from Medicinova. The institution of Dr. Oskarsson has received research support from Cytokinetics. The institution of Dr. Oskarsson has received research support from Calico. The institution of Dr. Oskarsson has received research support from Mitsubishi. The institution of Dr. Oskarsson has received research support from Tsumura. The institution of Dr. Oskarsson has received research support from Sanofi. The institution of Dr. Oskarsson has received research support from AZTherapeutics. The institution of Dr. Oskarsson has received research support from Orion. The institution of Dr. Oskarsson has received research support from Esaii.
Steven Ojemann	No disclosure on file
Shumaila Anwer, MD	An immediate family member of Dr. Anwer has received personal compensation for serving as an employee of Southwest Airlines. Dr. Anwer has stock in Boeing.
Kjetil Bjornevik, MD, PhD	The institution of Dr. Bjornevik has received research support from Michael J. Fox Foundation. The institution of Dr. Bjornevik has received research support from National Multiple Sclerosis Society. The institution of Dr. Bjornevik has received research support from Department of Defense.
Sifat Sharmin, PhD	Dr. Sharmin has nothing to disclose.
Siobhan Hutchinson, MD	Dr. Hutchinson has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hutchinson has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Dr. Hutchinson has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Teva.
Fredrik L. Piehl, MD, PhD	Dr. Piehl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Parexel/Chugai. The institution of Dr. Piehl has received research support from UCB. The institution of Dr. Piehl has received research support from Merck KGaA. Dr. Piehl has received personal compensation in the range of $10,000-$49,999 for serving as a member scientific advisory board with Swedish Medical products Agency.
Caio P. Costa	Mr. Costa has nothing to disclose.
Chad Carlson, MD, FAAN	Dr. Carlson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with US Department of Justice.
Chun-Yen Cheng	No disclosure on file
Akiko Matsunaga, MD	AKIKO MATSUNAGA, MD has nothing to disclose.
Rohit Das, MD, FAAN	Dr. Das has received personal compensation for serving as an employee of Concentra.
Margaret Gerbasi, PhD	Ms. Gerbasi has received personal compensation for serving as an employee of Sage Therapeutics, Inc.. Ms. Gerbasi has stock in Sage Therapeutics. Ms. Gerbasi has received intellectual property interests from a discovery or technology relating to health care.
Teresa Steininger	Teresa Steininger has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Teresa Steininger has stock in Jazz Pharmaceuticals.
Kan Xu	No disclosure on file
Jason Viereck, MD, PhD	Dr. Viereck has nothing to disclose.
Jared Bartell, MD	Dr. Bartell has nothing to disclose.
Heinz Wiendl, MD, FAAN	Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Johnson&Johnson / Janssen. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Idorsia. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for LTS. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for INmune Bio_Syneos Health. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Muna Therapeutics. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Myrobalan Therapeutics. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSL Group. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Red Nucleus. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Swiss Multiple Sclerosis Society. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teladoc Health. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Toleranzia . Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viatris. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz-Hexal. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cellerys. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Uniqure. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biocryst. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Galapagos. The institution of Dr. Wiendl has received research support from Biogen. The institution of Dr. Wiendl has received research support from Roche. The institution of Dr. Wiendl has received research support from Deutsche Forschungsgemeinschaft. The institution of Dr. Wiendl has received research support from European Union. The institution of Dr. Wiendl has received research support from Argenx. The institution of Dr. Wiendl has received research support from CSL Behring. The institution of Dr. Wiendl has received research support from Merck. The institution of Dr. Wiendl has received research support from UCB. Dr. Wiendl has received publishing royalties from a publication relating to health care. Dr. Wiendl has received publishing royalties from a publication relating to health care. Dr. Wiendl has received publishing royalties from a publication relating to health care.
Jalyce Taylor	Miss Taylor has nothing to disclose.
Sergi Martinez-Ramirez, MD	Dr. Martinez-Ramirez has nothing to disclose.
Trieste Francis	Miss Francis has nothing to disclose.
Shazia Mirza, MBBS	Dr. Mirza has nothing to disclose.
Shaweta Khosa	Ms. Khosa has nothing to disclose.
Leonard Verhagen Metman, MD, PhD	Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Verhagen Metman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitsubishi Tanabe. Dr. Verhagen Metman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus. Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerevel. Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers.
Christopher S. Mizenko	Mr. Mizenko has nothing to disclose.
John D. Steffens, MD	Dr. Steffens has nothing to disclose.
Marisara Dieppa, MD	Dr. Dieppa has nothing to disclose.
Nagma Dalvi, MD	Dr. Dalvi has nothing to disclose.
Saif Huda, MD	Dr. Huda has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Guidepoint.
Donald Gilbert, MD, FAAN	Dr. Gilbert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC Therapeutics. Dr. Gilbert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Illumina. Dr. Gilbert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Emalex Biosciences. The institution of Dr. Gilbert has received research support from NIMH. The institution of Dr. Gilbert has received research support from Emalex Biosciences. The institution of Dr. Gilbert has received research support from PTC Therapeutics. The institution of Dr. Gilbert has received research support from Department of Defense. Dr. Gilbert has received publishing royalties from a publication relating to health care. Dr. Gilbert has received publishing royalties from a publication relating to health care. Dr. Gilbert has received personal compensation in the range of $0-$499 for serving as a Medical Second Opinion Expert with Teldoc/Advanced Medical. Dr. Gilbert has received personal compensation in the range of $10,000-$49,999 for serving as a Medical Expert with Department of Health and Human Services/Vaccine Injury Compensation Program.
Scott Harcourt, PhD	Dr. Harcourt has nothing to disclose.
Yazan Nofal, MD	Dr. Nofal has nothing to disclose.
Brian C. Healy	The institution of Mr. Healy has received research support from Analysis Group. The institution of Mr. Healy has received research support from Bristol-Myers Squibb. The institution of Mr. Healy has received research support from Verily Life Sciences. The institution of Mr. Healy has received research support from Novartis. The institution of Mr. Healy has received research support from Merck Serono. The institution of Mr. Healy has received research support from Genzyme.
Maxine Dibue-Adjei, PhD	Maxine Dibue-Adjei has received personal compensation for serving as an employee of LivaNova PLC. Maxine Dibue-Adjei has stock in LivaNova PLC.
Bhavesh Trikamji, MD	Dr. Trikamji has nothing to disclose.
Julio Dotor Garcia-Soto	JULIO DOTOR GARCÍA-SOTO has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck . JULIO DOTOR GARCÍA-SOTO has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck, Biogen, Sanofi-Genzyme, Almirall, Teva, UCB, Novartis.
Lisa K. Peterson, PhD	The institution of Dr. Peterson has received research support from Kronus.
Aline Herlopian, MD	Dr. Herlopian has nothing to disclose.
Andre Valcour	No disclosure on file
Timothy Cunniff, PharmD	Dr. Cunniff has received personal compensation for serving as an employee of Paragon Biosciences. Dr. Cunniff has stock in Harmony Biosciences. Dr. Cunniff has stock in Emalex Biosciences.
Skarleth Cardenas Romero, Jr., MD	Mrs. Cardenas Romero has nothing to disclose.
Ramya Sampath	Mrs. Sampath has nothing to disclose.
Marie Varnet, MD	Dr. Varnet has nothing to disclose.
Nancy Lynn, Other	Ms. Lynn has nothing to disclose.
Linda Nguyen, MD, PhD	Dr. Nguyen has nothing to disclose.
Anthony M. Bradshaw, MD	Dr. Bradshaw has nothing to disclose.
Samir Alkabie, MD, MSc	Dr. Alkabie has nothing to disclose.
Sevim Erdem-Ozdamar, MD	No disclosure on file
Yoonhyuk Jang, MD, PhD	Mr. Jang has nothing to disclose.
Wayne Macfadden, MD, PT	Dr. Macfadden has received personal compensation for serving as an employee of Jazz pharma. Dr. Macfadden has stock in Jazz pharma.
Ashley Harrie	Ms. Harrie has nothing to disclose.
John DeLuca, PhD, ABPP	Dr. DeLuca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. DeLuca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. DeLuca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Celgene. Dr. DeLuca has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. DeLuca has received research support from Biogen.
Mhd Omar Subei, MD	Dr. Subei has nothing to disclose.
Kamala M. Rodrigues, MD	An immediate family member of Dr. Rodrigues has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Spine Biopharma. An immediate family member of Dr. Rodrigues has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for BlueJay Mobile-Health. An immediate family member of Dr. Rodrigues has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Spine Intervention Society. An immediate family member of Dr. Rodrigues has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for State Farm. An immediate family member of Dr. Rodrigues has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Kaiser Permanente. The institution of an immediate family member of Dr. Rodrigues has received research support from Relevant Medsystems.
Andrea S. Hakimi, DO	Dr. Hakimi has nothing to disclose.
Ahmed Abdelhak, MD	The institution of Dr. Abdelhak has received research support from German Multiple Sclerosis Society.
Carmen Calles, MD	Dr. Calles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi, Biogen, Roche, Teva, Novartis, Merck. Dr. Calles has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi, Teva, Biogen, Roche, Novartis, Merck.
Natasha Frost, MD, FAAN	Dr. Frost has nothing to disclose.
Maria E. Balbuena	Mrs. Balbuena has nothing to disclose.
Stig Wergeland, MD, PhD	Dr. Wergeland has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Wergeland has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Wergeland has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi. Dr. Wergeland has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Wergeland has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Wergeland has received research support from Biogen.
Helen Y. Zhou	Ms. Zhou has received research support from The Barry Goldwater Scholarship and Excellence in Education Foundation.
Samantha P. Myers	Ms. Myers has nothing to disclose.
Jacqueline Hirschey, MD	Dr. Hirschey has nothing to disclose.
Deborah Y. Bradshaw, MD, FAAN	The institution of Dr. Bradshaw has received research support from Cytokinetics. Dr. Bradshaw has received publishing royalties from a publication relating to health care.
Spyridoula Tsetsou, MD	Dr. Tsetsou has nothing to disclose.
Xiaojing Peng	Ms. Peng has nothing to disclose.
Michael L. Morgan, MD, PhD	Dr. Morgan has nothing to disclose.
Christopher Streib, MD	Dr. Streib has nothing to disclose.
Jens Kuhle, MD	Dr. Kuhle has nothing to disclose.
Bradley Collier	Dr. Collier has received personal compensation for serving as an employee of Labcorp. Dr. Collier has stock in Labcorp.
Eduardo Inacio Nascimento Andrade, MD	Dr. Nascimento Andrade has nothing to disclose.
Clare E. Schrodt, MD	Ms. Schrodt has nothing to disclose.
Kasra Sarhadi, MD	Dr. Sarhadi has nothing to disclose.
Bart Chwalisz, MD	Dr. Chwalisz has nothing to disclose.
Benedetta Nacmias	Benedetta Nacmias has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Khaled Ghoniem, MD	Dr. Ghoniem has nothing to disclose.
Lutz Achtnichts, MD	No disclosure on file
Christian Barro, MD, PhD	Dr. Barro has nothing to disclose.
Bonnie Glanz	The institution of Ms. Glanz has received research support from CMSC. The institution of Ms. Glanz has received research support from NIH.
Weiyi Ni	No disclosure on file
Lilit Mnatsakanyan, MD	Dr. Mnatsakanyan has nothing to disclose.
Sean D. Ruland, MD	Dr. Ruland has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up to Date. Dr. Ruland has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Law Firms.
Alanna Ritchie	No disclosure on file
Stefanie Mueller-Schunk	Stefanie Mueller-Schunk has nothing to disclose.
Soon-Tae Lee, MD, PhD	Prof. Lee has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Advanced Neural Technologies. Prof. Lee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Prof. Lee has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Celltrion. The institution of Prof. Lee has received research support from Roche. The institution of Prof. Lee has received research support from Celltrion. Prof. Lee has received intellectual property interests from a discovery or technology relating to health care.
Halley Alexander, MD	Dr. Alexander has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. The institution of Dr. Alexander has received research support from National Center for Advancing Translational Sciences, National Institute of Health, Grant KL2TR001421.
Ilana Lefkovitz, MD	Dr. Lefkovitz has nothing to disclose.
Raul Anwar Santos, MD	Dr. Santos has nothing to disclose.
Jonathan W. Mink, MD, PhD, FAAN	The institution of Dr. Mink has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. The institution of Dr. Mink has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Mink has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. Dr. Mink has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC Therapeutics. Dr. Mink has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Applied Therapeutics. Dr. Mink has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Mink has received research support from Neurogene. The institution of Dr. Mink has received research support from NIH. Dr. Mink has received publishing royalties from a publication relating to health care. Dr. Mink has received personal compensation in the range of $500-$4,999 for serving as a Member, Study Section with NINDS.
John C. Morris, MD, FAAN	Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CBR International Advisory Board. Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cure Alzheimers Fund. Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for LEADS Steering Commitee. The institution of Dr. Morris has received research support from NIH grants. Dr. Morris has received intellectual property interests from a discovery or technology relating to health care. Dr. Morris has received intellectual property interests from a discovery or technology relating to health care.
Shin Chang	Ms. Chang has nothing to disclose.
Richard H. Swartz, BSc MD PhD	The institution of Dr. Swartz has received research support from Heart and Stroke Foundation of Canada. The institution of Dr. Swartz has received research support from Ontario Brain Institute.
Gregory Owens, PhD	No disclosure on file
Rebecca Pollard, MD	Dr. Pollard has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Clinical and Translational Neurology.
Carla D. Zingariello, DO	The institution of Dr. Zingariello has received research support from ML Bio. The institution of Dr. Zingariello has received research support from Edgewise Therapeutics.
M. M. Mouradian, MD, FAAN	Dr. Mouradian has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HanAll Biopharma. Dr. Mouradian has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Society for Experimental Neurotherapeutics. Dr. Mouradian has stock in Alnylam, Eli Lilly. The institution of Dr. Mouradian has received research support from NIH, Michael J. Fox Foundation for Parkinson's Research; American Parkinson Disease Association. Dr. Mouradian has received intellectual property interests from a discovery or technology relating to health care. Dr. Mouradian has a non-compensated relationship as a Board of Directors with ANA that is relevant to AAN interests or activities.
Tammy L. Smith, MD, PhD	The institution of Dr. Smith has received research support from Alexion/AstraZeneca. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a attendee with Euroimmun Academy for travel support only.
Zakir I. Shaikh, MBBS	Dr. Shaikh has nothing to disclose.
Utku Uysal, MD	Dr. Uysal has nothing to disclose.
Francisco Barrero-Hernandez	No disclosure on file
Asim Roy, MD	Dr. Roy has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Jazz Pharma. Dr. Roy has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Harmony biosciences. Dr. Roy has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eisai . Dr. Roy has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Inspire. The institution of Dr. Roy has received research support from Jazz . The institution of Dr. Roy has received research support from Inspire. The institution of Dr. Roy has received research support from Avadel.
Craig Pfister	No disclosure on file
Ragy Saad	No disclosure on file
Sarah R. Durica, MD	An immediate family member of Dr. Durica has received personal compensation in the range of $100,000-$499,999 for serving as a Employee with Federal Aviation Administration.
Giulio Disanto, MD, PhD	The institution of Dr. Disanto has received research support from Swiss MS Sociery.
Scott K. Adney, MD	Dr. Adney has received research support from NINDS.
Gesine Respondek, MD	Gesine Respondek, MD has received personal compensation for serving as an employee of Hoffmann-La Roche. Gesine Respondek, MD has stock in Hoffmann-La Roche.
Jane B. Allendorfer, PhD	An immediate family member of Dr. Allendorfer has received personal compensation for serving as an employee of Northport Health Services, LLC. The institution of Dr. Allendorfer has received research support from National Institutes of Health. The institution of Dr. Allendorfer has received research support from Evelyn F. McKnight Brain Institute. The institution of Dr. Allendorfer has received research support from LivaNova, Inc. Dr. Allendorfer has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Cleveland Clinic. Dr. Allendorfer has received personal compensation in the range of $0-$499 for serving as a Examiner with University of Auckland. Dr. Allendorfer has received personal compensation in the range of $500-$4,999 for serving as a Speaker with International League Against Epilepsy. Dr. Allendorfer has a non-compensated relationship as a Scientific Program Committee Member with American Epilepsy Society that is relevant to AAN interests or activities. Dr. Allendorfer has a non-compensated relationship as a Editorial Board Member with Epilepsy and Behavior Reports that is relevant to AAN interests or activities.
Matthew Senjem	Matthew Senjem has received stock or an ownership interest from Align Technology, Inc.. Matthew Senjem has received stock or an ownership interest from Inovio Biomedical Corp.. Matthew Senjem has received stock or an ownership interest from Johnson & Johnson. Matthew Senjem has received stock or an ownership interest from Mesa Laboratories, Inc.. Matthew Senjem has received stock or an ownership interest from Nvidia Inc.. Matthew Senjem has received stock or an ownership interest from LHC Group, Inc.. Matthew Senjem has received stock or an ownership interest from Natus Medical Incorporated. Matthew Senjem has received stock or an ownership interest from Varex Imaging Corporation. Matthew Senjem has received personal compensation in the range of $100,000-$499,999 for serving as a IT Technical Specialist II with Mayo Clinic.
Alfred T. Frontera, Jr., MD	Dr. Frontera has nothing to disclose.
Steven R. Dunham, Jr., MD	Dr. Dunham has nothing to disclose.
Lawrence M. Samkoff, MD, FAAN	Dr. Samkoff has nothing to disclose.
Neha Atulkumar Singh, PhD	Dr. Singh has nothing to disclose.
Oezguer Yaldizli, MD	Dr. Yaldizli has nothing to disclose.
Tamara Castillo-Trivino, MD, MAS, FAAN	Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Castillo-Trivino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol-Myers Squibb. The institution of Dr. Castillo-Trivino has received research support from Basque Government.
Abhijit Lele	No disclosure on file
Frederik Barkhof, MD, PhD	Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Frederik Barkhof has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Combinostics. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IXICO. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EISAI.
Maria Laura Saladino	Maria Laura Saladino has nothing to disclose.
Brandon J. Lew	The institution of Mr. Lew has received research support from NIH.
Kore K. Liow, MD, FACP	The institution of Dr. Liow has received research support from UCB. The institution of Dr. Liow has received research support from Livanova. The institution of Dr. Liow has received research support from Biogen. The institution of Dr. Liow has received research support from Novartis. The institution of Dr. Liow has received research support from Eisai. The institution of Dr. Liow has received research support from Engage Therapeutics. The institution of Dr. Liow has received research support from SK Lifescience. The institution of Dr. Liow has received research support from Cerevel. The institution of Dr. Liow has received research support from Xenon. The institution of Dr. Liow has received research support from NeuroDerm. The institution of Dr. Liow has received research support from Avanir. The institution of Dr. Liow has received research support from Annovis. The institution of Dr. Liow has received research support from Acadia. The institution of Dr. Liow has received research support from Prothena. The institution of Dr. Liow has received research support from SAGE. The institution of Dr. Liow has received research support from Annovis. The institution of Dr. Liow has received research support from Cyclerion.
Laurie Gutmann	No disclosure on file
Nassim Matin, MD	Dr. Matin has nothing to disclose.
Alberto Ascherio, MD, PhD	The institution of Dr. Ascherio has received research support from NIH and US Department of Defense .
Amna A. Siddiqui, MBBS	Dr. Siddiqui has nothing to disclose.
Sandra Kletzel	No disclosure on file
Matthew Halber	Mr. Halber has nothing to disclose.
Devon Conway, MD	Dr. Conway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis Pharmaceuticals. Dr. Conway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca. Dr. Conway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Conway has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Conway has received research support from Novartis. The institution of Dr. Conway has received research support from BMS. The institution of Dr. Conway has received research support from Biogen.
Julie Silver	No disclosure on file
Paolo M. Moretti, MD	The institution of Dr. Moretti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie, Inc. The institution of an immediate family member of Dr. Moretti has received research support from NIH. The institution of an immediate family member of Dr. Moretti has received research support from VHA. The institution of an immediate family member of Dr. Moretti has received research support from DOD.
Dhanashri P. Miskin, MD	Dr. Miskin has nothing to disclose.
Jaime Masjuanvallejo	Jaime Masjuanvallejo has nothing to disclose.
Bridget Ollesch, MD	Dr. Ollesch has nothing to disclose.
Nicholas Thompson	No disclosure on file
Susan E. Duberstein Coad, MD	Dr. Duberstein Coad has nothing to disclose.
Bhooma R. Aravamuthan, MD, PhD	Dr. Aravamuthan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine Biosciences. An immediate family member of Dr. Aravamuthan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SK Life Science, Inc.. Dr. Aravamuthan has received research support from National Institute of Neurological Disorders and Stroke. Dr. Aravamuthan has received publishing royalties from a publication relating to health care.
Jason L. Aldred, MD, FAAN	Dr. Aldred has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Dr. Aldred has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Boston Scientific. Dr. Aldred has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Abbvie. Dr. Aldred has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen . Dr. Aldred has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan . Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Quadralynx. Dr. Aldred has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Aldred has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific. Dr. Aldred has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Aldred has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Abbvie. Dr. Aldred has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda. Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Adamas. Dr. Aldred has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Allergan. Dr. Aldred has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Boston Scientific. Dr. Aldred has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for TEVA. Dr. Aldred has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Medtronic. Dr. Aldred has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for US World Meds. Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Aldred has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sunovion. Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amneal. Dr. Aldred has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Aldred has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Arete Neuroscience, PLLC. The institution of Dr. Aldred has received research support from Biogen . The institution of Dr. Aldred has received research support from Abbvie. The institution of Dr. Aldred has received research support from Atara. The institution of Dr. Aldred has received research support from Takeda. The institution of Dr. Aldred has received research support from Merz. The institution of Dr. Aldred has received research support from AstraZeneca. The institution of Dr. Aldred has received research support from Neurocrine. The institution of Dr. Aldred has received research support from Aptinyx. The institution of Dr. Aldred has received research support from Cerevance. The institution of Dr. Aldred has received research support from Boston Scientific . The institution of Dr. Aldred has received research support from Parkinson Foundation . The institution of Dr. Aldred has received research support from Roche. The institution of Dr. Aldred has received research support from Theravance. The institution of Dr. Aldred has received research support from Triplet Therapeutics. The institution of Dr. Aldred has received research support from UCB. The institution of Dr. Aldred has received research support from Cerevel . The institution of Dr. Aldred has received research support from Sage Therapeutics. The institution of Dr. Aldred has received research support from Annovis. The institution of Dr. Aldred has received research support from Biovie. The institution of Dr. Aldred has received research support from Athira. The institution of Dr. Aldred has received research support from IRL. The institution of Dr. Aldred has received research support from NeuroDerm.
Roman Skowronski, MD, PhD	Dr. Skowronski has nothing to disclose.
Eddie Darton	No disclosure on file
Rachel Schrader	No disclosure on file
Alexandria Sadasivan, MD	Dr. Sadasivan has nothing to disclose.
Talita D'Aguiar Rosa, MD	Dr. D'Aguiar Rosa has nothing to disclose.
Abeer Safan, MD	Dr. Safan has nothing to disclose.
Martin Tolar, MD, PhD	Dr. Tolar has received personal compensation for serving as an employee of Alzheon. Dr. Tolar has received intellectual property interests from a discovery or technology relating to health care.
Lea Saab	Miss Saab has nothing to disclose.
Lester Melie-Garcia	No disclosure on file
Anne C. Van Cott, MD, FAAN	Dr. Van Cott has nothing to disclose.
Page B. Pennell, MD, FAAN	The institution of Dr. Pennell has received research support from NIH. The institution of an immediate family member of Dr. Pennell has received research support from Department of Defense. The institution of an immediate family member of Dr. Pennell has received research support from Environmental Protection Agency. The institution of an immediate family member of Dr. Pennell has received research support from NIH. The institution of an immediate family member of Dr. Pennell has received research support from Advanced Energy Consortium. Dr. Pennell has received publishing royalties from a publication relating to health care.
Aafreen Khan, MD	Dr. Khan has nothing to disclose.
L D. DeWitt, MD	Dr. DeWitt has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Sarah Marmol, MD	Dr. Marmol has nothing to disclose.
Jesus Manuel Martin Martinez	Jesus Manuel Martin Martinez has nothing to disclose.
Chen Zhao, MD	Dr. Zhao has nothing to disclose.
Nobuaki Yoshikura, MD, PhD	Dr. Yoshikura has nothing to disclose.
Ghazala Perven, MD	Dr. Perven has nothing to disclose.
Chahin Pachai	Chahin Pachai has received personal compensation for serving as an employee of Bristol Myers Squibb. Chahin Pachai has stock in Bristol-Myers Squibb.
Val J. Lowe, MD	Dr. Lowe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AVID Radiopharmaceutical. Dr. Lowe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Inc. The institution of Dr. Lowe has received research support from AVID Radiopharmaceuticals.
Maria Sol Román	No disclosure on file
Muhamed Barakovic	No disclosure on file
Donya Eizadkhah, MD	Dr. Eizadkhah has nothing to disclose.
Matthew S. Davitz, MD	Dr. Davitz has nothing to disclose.
Sandro Sorbi	Sandro Sorbi has nothing to disclose.
Jie Pan, MD	Dr. Pan has nothing to disclose.
Fadi B. Nahab, MD	Dr. Nahab has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Legal Consultation. Dr. Nahab has received intellectual property interests from a discovery or technology relating to health care.
Hirofumi Komaki	No disclosure on file
Yvette Crijnen	Yvette Crijnen has nothing to disclose.
Nanthaya Tisavipat, MD	Miss Tisavipat has nothing to disclose.
Vishakhadatta Mathur Kumaraswamy, MD	The institution of Dr. Mathur Kumaraswamy has received research support from Woolsey Pharmaceuticals.
Emily White, MD	Dr. White has nothing to disclose.
Gauruv Bose, MD	Dr. Bose has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Bose has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Bose has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva Pharmaceuticals. The institution of Dr. Bose has received research support from Multiple Sclerosis Society of Canada.
Daniel Ontaneda, MD, PhD, FAAN	Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech/Roche. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen Idec. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech/Roche. The institution of Dr. Ontaneda has received research support from NIH. The institution of Dr. Ontaneda has received research support from PCORI. The institution of Dr. Ontaneda has received research support from NMSS. The institution of Dr. Ontaneda has received research support from Genetech.
Rami Ben-Joseph, PhD	Dr. Ben-Joseph has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Dr. Ben-Joseph has stock in Jazz Pharmaceuticals.
Juichi Fujimori, MD	No disclosure on file
Ka-Ho Wong	The institution of Mr. Wong has received research support from The Sumaira Foundation . The institution of Mr. Wong has received research support from The Siegel Rare Neuroimmune Association.
David J. Seiden, MD	Dr. Seiden has received personal compensation for serving as an employee of Avadel Pharmaceuticals. Dr. Seiden has received stock or an ownership interest from Avadel Pharmaceuticals.
Nicole Walsh, NP	Mrs. Walsh has nothing to disclose.
Alexander D. Rae-Grant, MD, FAAN	Dr. Rae-Grant has received publishing royalties from a publication relating to health care. Dr. Rae-Grant has received publishing royalties from a publication relating to health care.
William O. Tatum IV, DO, FAAN	Dr. Tatum has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bioserenity. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Natus. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Defense Law Firm on behalf of a patient with epilepsy with funds donated to the Epilepsy Foundation of America. The institution of Dr. Tatum has received research support from Esai. The institution of Dr. Tatum has received research support from Mayo Clinic. The institution of Dr. Tatum has received research support from Liva Nova. The institution of Dr. Tatum has received research support from Engage Pharmaceuticals. The institution of Dr. Tatum has received research support from Xenon. Dr. Tatum has received intellectual property interests from a discovery or technology relating to health care. Dr. Tatum has received publishing royalties from a publication relating to health care. Dr. Tatum has received publishing royalties from a publication relating to health care. Dr. Tatum has received publishing royalties from a publication relating to health care. Dr. Tatum has a non-compensated relationship as a AAN Section Chair of Clinical Neurophysiology with AAN that is relevant to AAN interests or activities.
Jan A. Hillert, MD	Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Hillert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Hillert has received research support from Biogen. The institution of Dr. Hillert has received research support from Celgene. The institution of Dr. Hillert has received research support from Merck. The institution of Dr. Hillert has received research support from Novartis. The institution of Dr. Hillert has received research support from Sanofi. The institution of Dr. Hillert has received research support from Roche.
Padmaja Sudhakar, MD	Dr. Sudhakar has nothing to disclose.
Philip Scheltens, MD, PhD, FAAN	Dr. Scheltens has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NOVO NOrdisk.
Lakshman N. Arcot Jayagopal, MD	Dr. Arcot Jayagopal has nothing to disclose.
Paula R. Clemens, MD	The institution of Dr. Clemens has received research support from NS Pharma. The institution of Dr. Clemens has received research support from ReveraGen. The institution of Dr. Clemens has received research support from Amicus. The institution of Dr. Clemens has received research support from Sanofi. The institution of Dr. Clemens has received research support from Spark. The institution of Dr. Clemens has received research support from NIH. The institution of Dr. Clemens has received research support from MDA. The institution of Dr. Clemens has received research support from FDA.
Jonathan D. Zurawski, MD	The institution of Dr. Zurawski has received research support from The Race to Erase MS Foundation. The institution of Dr. Zurawski has received research support from Novartis Pharmaceuticals. The institution of Dr. Zurawski has received research support from I-Mab Biopharma . The institution of Dr. Zurawski has received research support from Elizabeth A. Kremer MS Research Foundation. The institution of Dr. Zurawski has received research support from Novartis.
Tyler L. Borko, BA	Mr. Borko has nothing to disclose.
Rocío Gómez, Other	Ms. Gómez has received personal compensation for serving as an employee of Roche Farma Spain, Medical Department.
Catherine Lewis	No disclosure on file
Keiko A. Fukuda, MD	Dr. Fukuda has nothing to disclose.
Jennifer Gudeman	Miss Gudeman has received personal compensation for serving as an employee of Avadel Pharmaceuticals. Miss Gudeman has stock in Avadel Pharmaceuticals.
Brooke Valdez	Brooke Valdez has nothing to disclose.
Lamees H. Alzyoud, MD	Dr. Alzyoud has nothing to disclose.
Shanna Patterson, MD	Dr. Patterson has nothing to disclose.
Delini Sivakumar, MD	Dr. Sivakumar has nothing to disclose.
Mughis Sheerani, MD	Dr. Sheerani has nothing to disclose.
Emily R. Fisher, MD	Dr. Fisher has nothing to disclose.
Stefano Malerba, MD	Dr. Malerba has nothing to disclose.
Robert I. Thompson-Stone, MD, FAAN	Dr. Thompson-Stone has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Conway Homer PC.
Shlok Sarin, MD	Mr. Sarin has nothing to disclose.
Sandra Vanotti	No disclosure on file
Michele Matarazzo, MD	Dr. Matarazzo has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for International Parkinson and Movement Disorders Society.
Aravindhan Veerapandiyan, MD	Dr. Veerapandiyan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AMO Pharma, AveXis, Biogen, Edgewise Therapeutics, FibroGen, Novartis, Pfizer, PTC Therapeutics, Sarepta Therapeutics, Inc., UCB Pharma, Catalyst, Entrada, Scholar Rock, Catalyst, Lupin. Dr. Veerapandiyan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. The institution of Dr. Veerapandiyan has received research support from AMO Pharma, Capricor Therapeutics, Edgewise Therapeutics, FibroGen, Muscular Dystrophy Association, Novartis, Parent Project Muscular Dystrophy, Pfizer, RegenxBio and Sarepta Therapeutics. Dr. Veerapandiyan has received personal compensation in the range of $5,000-$9,999 for serving as a MD with PPMD, MDA.
Tucker Harvey	No disclosure on file
Kon Chu	No disclosure on file
John Jiang	No disclosure on file
Rioghna R. Pittock	An immediate family member of Miss Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech, Inc.. An immediate family member of Miss Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage Therapeutics, Inc.. The institution of an immediate family member of Miss Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas. An immediate family member of Miss Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prime Therapeutics. An immediate family member of Miss Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. An immediate family member of Miss Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche/Genentech. The institution of an immediate family member of Miss Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. The institution of an immediate family member of Miss Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MedImmune/Viela Bio. An immediate family member of Miss Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB, Inc.. An immediate family member of Miss Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. An immediate family member of Miss Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffmann/LaRoche AG. An immediate family member of Miss Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for F. Hoffmann/LaRoche. The institution of an immediate family member of Miss Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of an immediate family member of Miss Pittock has received research support from Grifols. The institution of an immediate family member of Miss Pittock has received research support from NIH. The institution of an immediate family member of Miss Pittock has received research support from Viela Bio.MedImmune/Horizon. The institution of an immediate family member of Miss Pittock has received research support from Alexion Pharmaceuticals. The institution of an immediate family member of Miss Pittock has received research support from F. Hoffmann/LaRoche/Genentech. An immediate family member of Miss Pittock has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Miss Pittock has received intellectual property interests from a discovery or technology relating to health care.
Sepehr Sani	No disclosure on file
Lucas S. Silva, MD	Dr. Silva has nothing to disclose.
Sajeevan Sujanthan	Mr. Sujanthan has nothing to disclose.
Melissa A. Wright, MD	Dr. Wright has nothing to disclose.
Anu Jacob, MD	Dr. Jacob has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ALEXION.
Lara Bardoneschi	No disclosure on file
Annelly Buré-Reyes	Annelly Buré-Reyes has nothing to disclose.
Drushti D. Birwatkar	Miss Birwatkar has nothing to disclose.
Timothy L. Vollmer, MD, FAAN	The institution of Dr. Vollmer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen IDEC. The institution of Dr. Vollmer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech/Roche. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siranax. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Meyers Squib. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viela Bios. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. The institution of Dr. Vollmer has received research support from Rocky Mountain MS Center. The institution of Dr. Vollmer has received research support from Biogen. The institution of Dr. Vollmer has received research support from Actelion. The institution of Dr. Vollmer has received research support from Genentech/Roche. The institution of Dr. Vollmer has received research support from Anokion. The institution of Dr. Vollmer has received research support from TG Therapeutics.
Katherine A. Zarroli, MD	Dr. Zarroli has nothing to disclose.
Suma Shah, MD	Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Shah has received research support from Biogen. The institution of Dr. Shah has received research support from National MS Society.
Matthew Tae	Mr. Tae has nothing to disclose.
Seema Nagpal, MD, FAAN	Dr. Nagpal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. Dr. Nagpal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mirati. Dr. Nagpal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Servier. Dr. Nagpal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kiyatec. Dr. Nagpal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Telix. Dr. Nagpal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Midatech.
Serdar Kazanci, MD	Dr. Kazanci has nothing to disclose.
Michael Reznik, MD	Dr. Reznik has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Morrison Mahoney. The institution of Dr. Reznik has received research support from NIDUS.
Alessandro Cagol	No disclosure on file
Adrian Laxton	No disclosure on file
Katrina Bernardo, MD	Dr. Bernardo has nothing to disclose.
Diana Andino, MD	Dr. Andino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Multiple Sclerosis American Association. Dr. Andino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Andino has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Andino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon.
Britney Barrera	Ms. Barrera has nothing to disclose.
Araya Puwanant, MD	The institution of Dr. Puwanant has received research support from Muscular Dystrophy Association. The institution of Dr. Puwanant has received research support from NIH/NINDS. The institution of Dr. Puwanant has received research support from NIH/NINDS.
Michelle Anlacan	Michelle Anlacan has received personal compensation in the range of $0-$499 for serving as a Consultant for Torrent Philippines. Michelle Anlacan has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Medichem Philippines. Michelle Anlacan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Hi Eisai Philippines. Michelle Anlacan has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Natrapharm Philippines. Michelle Anlacan has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Alzheimer's disease association of the philippines. Michelle Anlacan has received research support from Philippine Council for Health Research and Development. Michelle Anlacan has received research support from Philippine Neurological Association.
Gina M. Andraos, MD	Dr. Andraos has nothing to disclose.
Virginia J. Howard, PhD	The institution of Dr. Howard has received research support from NIH. The institution of an immediate family member of Dr. Howard has received research support from NIH.
Rosario Blasco Quilez	Rosario Blasco Quilez has nothing to disclose.
Jeffrey A. Cohen, MD	Dr. Cohen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Convelo. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FiND. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for INMune. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celltrion. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sage.
Dana Most, MD, PhD	Dr. Most has nothing to disclose.
Soonmyung Hwang	Mr. Hwang has nothing to disclose.
Mariona Hervas Pujol	Mariona Hervas Pujol has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi, Merk, Bayer, Biogen, Almirall.
Anooshah Ata, MD	Dr. Ata has nothing to disclose.
Nicolas Madigan, MD	Dr. Madigan has nothing to disclose.
Nicole Brescia, MD	Dr. Brescia has nothing to disclose.
Mirasol Forcadela, MD	Dr. Forcadela has nothing to disclose.
Stephanie V. Meier	Miss Meier has nothing to disclose.
Italo Karmann Aventurato, MD	Dr. Karmann Aventurato has received research support from Coordenadoria de Aperfeiçoamento de Pessoal de Ensino Superior (CAPES). Dr. Karmann Aventurato has received research support from Fundação de Amparo a Pesquisa do Estado de São Paulo (FAPESP).
Bharathy E. Sundaram, MD	Dr. Sundaram has nothing to disclose.
Stephen B. Tatter, MD	The institution of Dr. Tatter has received research support from Monteris Medical, Inc. The institution of Dr. Tatter has received research support from Arbor Pharmaceuticals. Dr. Tatter has received intellectual property interests from a discovery or technology relating to health care.
Imran H. Quraishi, MD, PhD	The institution of Dr. Quraishi has received research support from NeuroPace. The institution of Dr. Quraishi has received research support from Biogen. The institution of Dr. Quraishi has received research support from Praxis Precision Medicines.
Suzanne Liu, MD	The institution of an immediate family member of Dr. Liu has received research support from NIH.
Jerome Honnorat, MD, PhD	The institution of Jerome Honnorat, MD, PhD has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for journal of neurology.
Maayan J. Yakir, MD	Dr. Yakir has nothing to disclose.
Corneliu C. Luca, MD	Dr. Luca has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston Scientific. Dr. Luca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Signant Health. Dr. Luca has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott.
Mat D. Davis	Mat D. Davis has received personal compensation for serving as an employee of Teva pharmaceuticals. Mat D. Davis has received stock or an ownership interest from Teva Pharmaceuticals.
Eileen Leary, PhD	Dr. Leary has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Dr. Leary has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Proper. Dr. Leary has stock in Jazz Pharmaceuticals.
Sadia Nishat, MBBS, FCPS	Dr. Nishat has nothing to disclose.
Nicholas A. Frost, MD, PhD	The institution of Dr. Frost has received research support from Simons Foundation. The institution of Dr. Frost has received research support from National Institutes of Health.
Kalea L. Colletta, DO	Dr. Colletta has nothing to disclose.
John E. Greenlee, MD, FAAN	Dr. Greenlee has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink. Dr. Greenlee has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Zeigler Cohen Roche. Dr. Greenlee has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Sommers Schwartz PC. Dr. Greenlee has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for St Francis Hospital. Dr. Greenlee has received publishing royalties from a publication relating to health care. Dr. Greenlee has received publishing royalties from a publication relating to health care.
Marwan N. Sabbagh, MD, FAAN	Dr. Sabbagh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genetech=Roche. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Sabbagh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Synaptogenix. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant Health. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Anavex. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prothena. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cognito Therapeutics. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for CervoMed. Dr. Sabbagh has stock in Neurotau. Dr. Sabbagh has stock in Seq Biomarque. Dr. Sabbagh has stock in uMethod Health. Dr. Sabbagh has stock in Athira. Dr. Sabbagh has stock in Lighthouse Pharmaceuticals. Dr. Sabbagh has stock in Alzheon. The institution of Dr. Sabbagh has received research support from NIH. The institution of Dr. Sabbagh has received research support from ADDF.
Austin Oblack, DO	Dr. Oblack has nothing to disclose.
Gerd Meyer Zu Horste, MD	Dr. Meyer Zu Horste has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for LFB. The institution of Dr. Meyer Zu Horste has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Meyer Zu Horste has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. The institution of Dr. Meyer Zu Horste has received research support from Merck KGaA. The institution of Dr. Meyer Zu Horste has received research support from Roche. Dr. Meyer Zu Horste has received intellectual property interests from a discovery or technology relating to health care.
Keith A. Josephs, Jr., MD, FAAN	Dr. Josephs has nothing to disclose.
Vishal Mandge, MD	Dr. Mandge has nothing to disclose.
Joyce Suhy, PhD	Dr. Suhy has nothing to disclose.
Jingxiao Zhang	Dr. Zhang has nothing to disclose.
Liane E. Hunter, MD, PhD	Dr. Hunter has nothing to disclose.
Christa O'hana S. Nobleza, MD	Dr. Nobleza has nothing to disclose.
Christoph Wandel, MD, PhD	Christoph Wandel, MD, PhD has received personal compensation for serving as an employee of F Hoffmann-LaRoche AG. Christoph Wandel, MD, PhD has stock in F Hoffmann-La Roceh AG, Basel, CH; Bayer AG, Leverkusen, FRG.
Kyung Il Park	No disclosure on file
Mariam Hull, MD	Dr. Hull has received publishing royalties from a publication relating to health care.
Samuel M. Jones, MD	Dr. Jones has nothing to disclose.
Alyssa Westring	No disclosure on file
Richard K. Bogan, MD	Dr. Bogan has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Harmony. Dr. Bogan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz. Dr. Bogan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Bogan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avadel. Dr. Bogan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merck. Dr. Bogan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Harmony. Dr. Bogan has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Jazz. The institution of Dr. Bogan has received research support from Jazz Pharmaceuticals. The institution of Dr. Bogan has received research support from Harmony . The institution of Dr. Bogan has received research support from Philips. The institution of Dr. Bogan has received research support from Eisai. The institution of Dr. Bogan has received research support from Fresca. The institution of Dr. Bogan has received research support from Avadel. The institution of Dr. Bogan has received research support from Takeda. The institution of Dr. Bogan has received research support from Suven. The institution of Dr. Bogan has received research support from Axsome. Dr. Bogan has received intellectual property interests from a discovery or technology relating to health care. Dr. Bogan has a non-compensated relationship as a Chair with National Sleep Foundation that is relevant to AAN interests or activities.
Eddie Jones, BA	Eddie Jones, BA has nothing to disclose.
Anton P. Porsteinsson, MD	Dr. Porsteinsson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ONO Pharmaceuticals. Dr. Porsteinsson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Porsteinsson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Porsteinsson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IQVIA. Dr. Porsteinsson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for WebMD. Dr. Porsteinsson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Porsteinsson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Otsuka. Dr. Porsteinsson has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia. Dr. Porsteinsson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Functional Neuromodulation. Dr. Porsteinsson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Xenon Pharmaceuticals. Dr. Porsteinsson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Porsteinsson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cognitive Research Corporation. Dr. Porsteinsson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Athira. Dr. Porsteinsson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Porsteinsson has received research support from Alector. The institution of Dr. Porsteinsson has received research support from Eisai. The institution of Dr. Porsteinsson has received research support from Eli Lilly. The institution of Dr. Porsteinsson has received research support from Athira. The institution of Dr. Porsteinsson has received research support from Genentech/Roche. The institution of Dr. Porsteinsson has received research support from Cassava. The institution of Dr. Porsteinsson has received research support from Vaccinex.
Benjamin Hampstead	No disclosure on file
Henrique J. Prado, MD	No disclosure on file
Eleni Drakou, MD	Dr. Drakou has nothing to disclose.
Cade M. Haynie	Mr. Haynie has nothing to disclose.
Julie Hviid Hahn-Pedersen	Julie Hviid Hahn-Pedersen has received personal compensation for serving as an employee of Novo Nordisk A/S. Julie Hviid Hahn-Pedersen has stock in Novo Nordisk A/S.
Alberto R. Aguirre, MD	Dr. Aguirre has nothing to disclose.
Lilly East, PhD	Mrs. East has received personal compensation for serving as an employee of Sarepta Therapeutics.
Cristina Granziera, MD, PhD	Dr. Granziera has nothing to disclose.
Urvi G. Desai, MD, FAAN	Dr. Desai has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Desai has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fulcrum. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx.
Christian C. Prusinski, DO	Dr. Prusinski has nothing to disclose.
June Yoshii-Contreras, MD	Dr. Yoshii-Contreras has nothing to disclose.
Cheryl Fields, DO	Dr. Fields has nothing to disclose.
Shufang Wang	No disclosure on file
David P. Bissig, MD	Dr. Bissig has received personal compensation in the range of $100,000-$499,999 for serving as a Physician with University of California - Davis.
Vijay K. Ramanan, MD, PhD	The institution of Dr. Ramanan has received research support from the National Institutes of Health. The institution of Dr. Ramanan has received research support from the Mangurian Foundation for Lewy Body Disease Research. The institution of Dr. Ramanan has received research support from as part of clinical trials sponsored by the Alzheimer's Association, Eisai, the Alzheimer's Treatment and Research Institute at USC, and Transposon Therapeutics, Inc.. The institution of Dr. Ramanan has received research support from Medscape. Dr. Ramanan has received personal compensation in the range of $500-$4,999 for serving as a Conference Speaker/Organizer (Honoraria) with AANI.
Jose Luis Sanchez Menoyo, MD	Dr. Sanchez Menoyo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Sanchez Menoyo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Sanchez Menoyo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Sanchez Menoyo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Sanchez Menoyo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Sanjeet S. Grewal, MD	Sanjeet S. Grewal, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic.
Izanne Roos	Izanne Roos has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Izanne Roos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Izanne Roos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Izanne Roos has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Izanne Roos has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Izanne Roos has received research support from MSIF-ARSEP. Izanne Roos has received research support from Melbourne Research Scholarship. Izanne Roos has received personal compensation in the range of $0-$499 for serving as a travel support with Merck. Izanne Roos has received personal compensation in the range of $0-$499 for serving as a travel support with Roche.
Peter Bede, MD, PhD	Dr. Bede has nothing to disclose.
Connor Goo	Mr. Goo has nothing to disclose.
Douglas L. Arnold, MD, FAAN	Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Frequency Therapeutics. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xfacto communications. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Find therapeutics. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Idorsia. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kiniksa. Dr. Arnold has stock in NeuroRx.
Johanna Oechtering	No disclosure on file
Katherine D. Mathews, MD, FAAN	Dr. Mathews has received personal compensation for serving as an employee of Avidity Bioscience. The institution of Dr. Mathews has received research support from NIH. The institution of Dr. Mathews has received research support from Centers for Disease Control and Prevention. The institution of Dr. Mathews has received research support from Muscular Dystrophy Association . The institution of Dr. Mathews has received research support from Friedreich's Ataxia Research Alliance . The institution of Dr. Mathews has received research support from Sarepta . The institution of Dr. Mathews has received research support from Pfizer. The institution of Dr. Mathews has received research support from Reata . The institution of Dr. Mathews has received research support from PTC Therapeutics, Inc. The institution of Dr. Mathews has received research support from Italfarmaco . The institution of Dr. Mathews has received research support from AMO. The institution of Dr. Mathews has received research support from FibroGen. The institution of Dr. Mathews has received research support from Capricor. The institution of Dr. Mathews has received research support from edgewise. The institution of Dr. Mathews has received research support from biogen.
Michael Hutchinson, MD	Dr. Hutchinson has nothing to disclose.
Aditi V. Varma-Doyle, MD	Dr. Varma-Doyle has nothing to disclose.
Cayla Vila, MD	Dr. Vila has nothing to disclose.
Thomas Thesen, PhD	Prof. Thesen has nothing to disclose.
Stephanie L. Bissonnette, DO	The institution of Dr. Bissonnette has received research support from SAGE Therapeutics. The institution of Dr. Bissonnette has received research support from Huntington's Disease Society of America.
Pitcha Chompoopong, MD	Dr. Chompoopong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alnylam.
Ralph H. Benedict, PhD	Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Benedict has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Roche. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Benedict has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Benedict has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Brystal Mier Squibb. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for EMD Serono. The institution of Dr. Benedict has received research support from Genzyme. The institution of Dr. Benedict has received research support from Biogen. The institution of Dr. Benedict has received research support from Bristol Myer Squib. Dr. Benedict has received intellectual property interests from a discovery or technology relating to health care.
Grace E. Vitek, MD	Ms. Vitek has nothing to disclose.
Claire Bridel	Claire Bridel has nothing to disclose.
Myriam Abdennadher, MD	The institution of Dr. Abdennadher has received research support from Grinspoon Foundation. The institution of Dr. Abdennadher has received research support from Boston University CTSI grant. The institution of Dr. Abdennadher has received research support from Alzheimer's Disease Research Center at Boston University. The institution of Dr. Abdennadher has received research support from Alzheimer's Disease Research Center at Boston University.
Linda P. Lowes, PT PhD	The institution of Ms. Lowes has received research support from Sarepta Therapeutics.
Soo Hwan Park	Mr. Park has nothing to disclose.
Sarah Wahlster, MD	Dr. Wahlster has nothing to disclose.
Ryan Hays, MD, MBA, FAES, FAAN	Dr. Hays has nothing to disclose.
Eva-Maria Wicklein, MD	Dr. Wicklein has received personal compensation for serving as an employee of Bayer AG.
Rayan S. Hassan, PhD	Dr. Hassan has nothing to disclose.
Lucienne Costa C. Franca, Sr., PhD	Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Almirall. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biopas. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristoll-Mayer. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ipsen. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche.
Yarema Bezchlibnyk	Yarema Bezchlibnyk has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Yarema Bezchlibnyk has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for PMT Inc. Yarema Bezchlibnyk has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbott. Yarema Bezchlibnyk has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Boston Scientific. Yarema Bezchlibnyk has received research support from Medtronic.
Diego Silva	Diego Silva has received personal compensation for serving as an employee of BMS. Diego Silva has received stock or an ownership interest from BMS.
Arenn Faye Carlos, MD	Dr. Carlos has nothing to disclose.
Evrim Aksu-Menges	Ms. Aksu-Menges has nothing to disclose.
Mary M. Machulda, PhD	The institution of Dr. Machulda has received research support from NIH.
Ilena George, MD	The institution of Dr. George has received research support from Biogen.
Alessandro Serra, MD	Dr. Serra has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen Idec. Dr. Serra has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb.
Harjot Hansra, MD	Dr. Hansra has nothing to disclose.
Emily Herreshoff	No disclosure on file
Sean I. Savitz, MD	Dr. Savitz has nothing to disclose.
Laura Navarro	Laura Navarro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Laura Navarro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen idec. Laura Navarro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme.
Diana A. Madrid, MS	Miss Madrid has received personal compensation in the range of $10,000-$49,999 for serving as a Grantee with Institute of Internation Education. Miss Madrid has received personal compensation in the range of $500-$4,999 for serving as a Early Investigator Travel Award with American Society for Bone and Mineral Research. Miss Madrid has received personal compensation in the range of $0-$499 for serving as a Travel Award with American Neurological Association.
Nupur Greene	Nupur Greene has nothing to disclose.
Tag-Eldin Sokrab, MD, PhD, FAAN	Dr. Sokrab has nothing to disclose.
Prashanthi Vemuri, PhD	The institution of Dr. Vemuri has received research support from NIH.
Drew S. Kern, MD, FAAN	Dr. Kern has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. The institution of Dr. Kern has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. The institution of Dr. Kern has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Kern has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott. The institution of Dr. Kern has received research support from Boston Scientific. The institution of Dr. Kern has received research support from AbbVie Pharmaceticals. Dr. Kern has received research support from Medtronic.
Lindsay Tetreault, MD, PhD	Dr. Tetreault has nothing to disclose.
Hans-Peter Hartung, MD, FAAN	Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS Celgene. Dr. Hartung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Geneuro. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers Neurology.
Anat Mirelman	Anat Mirelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie . Anat Mirelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bial. The institution of Anat Mirelman has received research support from Department of Defense. The institution of Anat Mirelman has received research support from MJFF. The institution of Anat Mirelman has received research support from JPND. The institution of Anat Mirelman has received research support from EU-Horizon 2020.
Stephen Hantus, MD	Dr. Hantus has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Hantus has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB.
Matthew Brier, MD	Dr. Brier has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. The institution of Dr. Brier has received research support from NIH.
Jennifer Whitwell, PhD	Dr. Whitwell has nothing to disclose.
Rebecca L. Hurst, MD	Dr. Hurst has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for The Paul Wilkinson law firm.
Luisa M. Villar	Luisa M. Villar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Luisa M. Villar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol-Myers Squibb. Luisa M. Villar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Luisa M. Villar has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Luisa M. Villar has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Luisa M. Villar has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Luisa M. Villar has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Luisa M. Villar has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol-Myers Squibb. The institution of Luisa M. Villar has received research support from European Union. The institution of Luisa M. Villar has received research support from Instituto de Salud Carlos III (Spanish Goverment).
Sarah Shapiro	Miss Shapiro has nothing to disclose.
Alexander Doyle, MD	Dr. Doyle has nothing to disclose.
Matthew Feldman, MD	Dr. Feldman has nothing to disclose.
Mustafa S. Siddiqui, MD, FAAN	Dr. Siddiqui has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Boston Scientific Neuromodulation. Dr. Siddiqui has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Siddiqui has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for United States Department of Justice. The institution of Dr. Siddiqui has received research support from Boston Scientific Neuromodulation. The institution of Dr. Siddiqui has received research support from Abbvie. Dr. Siddiqui has received research support from Michael J. Fox Foundation. The institution of Dr. Siddiqui has received research support from National Institute of Health .
Marlieke De Bruijn	No disclosure on file
Rachael Potter	No disclosure on file
Gloria I. Ortiz Guerrero, MD	Dr. Ortiz Guerrero has nothing to disclose.
Emma Wallace, MD, PhD	Dr. Wallace has nothing to disclose.
Natalie Smith, MD	Ms. Smith has nothing to disclose.
Manasa Sudheendra, MBBS	Dr. Sudheendra has nothing to disclose.
John Harsh, PhD	Dr. Harsh has nothing to disclose.
Eduardo Aguera Morales, MD, PhD	Dr. Aguera Morales has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Aguera Morales has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis .
Conor T. Flavin, MD	Dr. Flavin has nothing to disclose.
Merja Soilu-Hanninen	Merja Soilu-Hanninen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Merja Soilu-Hanninen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Merja Soilu-Hanninen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. The institution of Merja Soilu-Hanninen has received research support from Biogen.
Virginia DeLasHeras	Virginia DeLasHeras has received personal compensation for serving as an employee of NOVARTIS.
Brian J. Murray, MD, FAAN	The institution of Dr. Murray has received research support from Wake Up Narcolepsy. Dr. Murray has received publishing royalties from a publication relating to health care.
Gian D. Pal, MD	Dr. Pal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint. Dr. Pal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Pal has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for CLRM Law. Dr. Pal has stock in Baudax Bio. The institution of Dr. Pal has received research support from National Institutes of Health. The institution of Dr. Pal has received research support from Parkinson's Foundation. Dr. Pal has received personal compensation in the range of $500-$4,999 for serving as a Consultant with RKV Firm.
Erik Middlebrooks	No disclosure on file
Meghan Zorn, PA	Ms. Zorn has nothing to disclose.
Jerry R. Mendell, MD, FAAN	Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vertex. Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta Therapeutics . The institution of Dr. Mendell has received research support from Sarepta.
Lilly Chen	Lilly Chen has received personal compensation for serving as an employee of Boston Scientific .
Brin Freund, MD	Dr. Freund has received research support from Mayo Clinic.
Akio Kimura, MD	Dr. Kimura has nothing to disclose.
Jessica Langbaum, PhD	Dr. Langbaum has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alector. Dr. Langbaum has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Denovo Biopharma. Dr. Langbaum has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Langbaum has received research support from Eli Lilly.
Ashley Raedy, MD	Dr. Raedy has nothing to disclose.
David Leppert, MD	Dr. Leppert has received personal compensation for serving as an employee of GeNeuro. Dr. Leppert has received personal compensation for serving as an employee of GeNeuro. Dr. Leppert has received personal compensation for serving as an employee of Geneuro. Dr. Leppert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Leppert has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Leppert has received personal compensation in the range of $0-$499 for serving as a Consultant for Orion. Dr. Leppert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Leppert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Quanterix. Dr. Leppert has stock in Novartis.
Bryce Chang, MD	Mr. Chang has nothing to disclose.
Gholam Adeli, MD	Dr. Adeli has nothing to disclose.
Elise Poole	Ms. Poole has nothing to disclose.
Jon Riolo, PhD	Dr. Riolo has received personal compensation for serving as an employee of Bristol Myers Squib.
Claire Creutzfeldt, MD	The institution of Dr. Creutzfeldt has received research support from NINDS. The institution of Dr. Creutzfeldt has received research support from NINR.
Patrice LaLive, MD	Dr. LaLive has nothing to disclose.
Jessica Zwerling, MD, FAAN	Dr. Zwerling has nothing to disclose.
Michael R. Zimbric, MD	Dr. Zimbric has received personal compensation in the range of $0-$499 for serving as a Survey volunteer with Opinionsite.
Shayan Khan	No disclosure on file
Mac DeHart-McCoyle, DO	Dr. DeHart-McCoyle has nothing to disclose.
Louise R. Rodino-Klapac	Ms. Rodino-Klapac has received personal compensation for serving as an employee of Sarepta Therapeutics, Inc.. Ms. Rodino-Klapac has received stock or an ownership interest from Sarepta Therapeutics. Ms. Rodino-Klapac has received intellectual property interests from a discovery or technology relating to health care.
Benjamin H. Brinkmann, PhD	Dr. Brinkmann has received personal compensation in the range of $0-$499 for serving as a Consultant for Otsuka Pharmaceuticals. Dr. Brinkmann has stock in Cadence Neuroscience. The institution of Dr. Brinkmann has received research support from Epilepsy Foundation of America. The institution of Dr. Brinkmann has received research support from National Institutes of Health. The institution of Dr. Brinkmann has received research support from National Institutes of Health. The institution of Dr. Brinkmann has received research support from UNEEG A/S. The institution of Dr. Brinkmann has received research support from Seer Medical Pty. Dr. Brinkmann has received intellectual property interests from a discovery or technology relating to health care. Dr. Brinkmann has a non-compensated relationship as a Co-Investigator with Medtronic Inc. that is relevant to AAN interests or activities.
Xavier Montalban, MD, PhD, FAAN	The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck/ EMD Serono. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffmann-La Roche. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Actelion/ Janssen. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BMS/ Celgene. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/ Genzyme. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion/ Janssen. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS/ Celgene. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/ EMD Serono. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffmann-La Roche. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic Therapeutics. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viatris/ Mylan. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. The institution of Dr. Montalban has received research support from Biogen. The institution of Dr. Montalban has received research support from Hoffmann-La Roche. The institution of Dr. Montalban has received research support from Sanofi/ Genzyme. The institution of Dr. Montalban has received research support from Merck/ EMD Serono. The institution of Dr. Montalban has received research support from Novartis. The institution of Dr. Montalban has received research support from Teva Pharmaceuticals. The institution of Dr. Montalban has received research support from Actelion/ Janssen. The institution of Dr. Montalban has received research support from BMS/ Celgene.
Vibhor Krishna	No disclosure on file
Pascal Benkert	No disclosure on file
Marcus D'Souza, MD	Dr. D'Souza has nothing to disclose.
Teodora Pene Dumitrescu	No disclosure on file
Emily Spoth	No disclosure on file
Shameer Rafee, MBBS	Dr. Rafee has nothing to disclose.
Jennifer A. Vermilion, MD	The institution of Dr. Vermilion has received research support from Tourette Association of America, American Academy of Neurology and American Brain Foundation. The institution of Dr. Vermilion has received research support from Centers for Disease Control.
Atul Mahableshwarkar	Atul Mahableshwarkar has received personal compensation for serving as an employee of Emalex Biosciences. Atul Mahableshwarkar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ecor1 Capital. Atul Mahableshwarkar has stock in Johnson & Johnson.
Karlien Mul	The institution of Karlien Mul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avidity Biosciences.
John A. Hey, PhD	Dr. Hey has received personal compensation for serving as an employee of Alzheon. Dr. Hey has stock in Alzheon. Dr. Hey has stock in Alzheon. Dr. Hey has received intellectual property interests from a discovery or technology relating to health care.
Luis Brieva Ruiz, MD	Dr. Brieva Ruiz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for All comercial companies interested in Multiple Sclerosis. Dr. Brieva Ruiz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Al comercial companies in Multiple Sclerosis. The institution of Dr. Brieva Ruiz has received research support from Carlos III Institut. Madrid. Spain..
Jonathan Carlson	No disclosure on file
Charles Esenwa, MD	Dr. Esenwa has nothing to disclose.
Cynthia Zheng	Ms. Zheng has nothing to disclose.
Andrea Lendaris, MD, MS	Dr. Lendaris has nothing to disclose.
Vikas Kotagal, MD, FAAN	Dr. Kotagal has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorders Society. The institution of Dr. Kotagal has received research support from NIH. The institution of Dr. Kotagal has received research support from VA Healthcare System.
Joseph Volpe, PhD	Dr. Volpe has received personal compensation for serving as an employee of Labcorp.
Paul D. Crane, MD	Dr. Crane has nothing to disclose.
Sawsan (Susan) R. Abushakra, MD	Dr. Abushakra has received personal compensation for serving as an employee of Alzheon Inc. Dr. Abushakra has stock in Alzheon Inc. The institution of Dr. Abushakra has received research support from NIA. Dr. Abushakra has received intellectual property interests from a discovery or technology relating to health care.
Neena Viswanathan, MD	Dr. Viswanathan has nothing to disclose.
Keiko Higuchi, Other	Miss Higuchi has received personal compensation for serving as an employee of Sanofi. Miss Higuchi has received personal compensation for serving as an employee of Novartis. Miss Higuchi has received personal compensation for serving as an employee of Gilead Sciences . Miss Higuchi has received personal compensation for serving as an employee of Pfizer Inc. . Miss Higuchi has received personal compensation for serving as an employee of Zynx Health Inc. . Miss Higuchi has received stock or an ownership interest from Sanofi. Miss Higuchi has received stock or an ownership interest from Gilead. Miss Higuchi has received stock or an ownership interest from Novartis.
Shilpa Chitnis, MD, PhD, FANA, FAAN	Dr. Chitnis has received publishing royalties from a publication relating to health care.
Akira Takekoshi	Akira Takekoshi has nothing to disclose.
Marie Charmaine C. Sy, MD	Marie Charmaine Sy has nothing to disclose.
Jin Myoung Seok, MD	Jin Myoung Seok has nothing to disclose.
Pedro Rosa Neto, MD, PhD	Dr. Rosa Neto has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk.
William J. Therriault	Mr. Therriault has nothing to disclose.
Angela T. Kwan, MSc	Miss Kwan has nothing to disclose.
Soo Hyun Ahn, MD	Dr. Ahn has nothing to disclose.
Mohammad Jamil Ahmad, MD	Dr. Ahmad has nothing to disclose.
Javier Sotoca Fernandez	No disclosure on file
Shawn A. Candler, MD	Dr. Candler has received research support from Jazz Pharmaceuticals .
Mohamed Darwish, MD	Dr. Darwish has nothing to disclose.
Rana K. Zabad, MD, FAAN	Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene/BMS. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck Serono. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva Neurosciences. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genentech. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS. The institution of Dr. Zabad has received research support from Adamas. The institution of Dr. Zabad has received research support from Biogen. The institution of Dr. Zabad has received research support from Novartis. The institution of Dr. Zabad has received research support from Sun Pharma. The institution of Dr. Zabad has received research support from Parexel & MedDay Pharmaceuticals.
Sookyong Koh, MD, PhD	No disclosure on file
Daniel Zhou, MD	Dr. Zhou has nothing to disclose.
Jennifer Shoskes, PharmD	No disclosure on file
Monica Saray R. Rodríguez, Sr., MD	Dr. Rodríguez has nothing to disclose.
Jack J. Lin, MD	Dr. Lin has received stock or an ownership interest from StimScience. Dr. Lin has received stock or an ownership interest from IFovea.
Robert Freundlich, MD	Dr. Freundlich has nothing to disclose.
Matthew Chappell	No disclosure on file
Whitney Brandon	No disclosure on file
Hadi Mohammad Khanli, MD	Dr. Mohammad Khanli has nothing to disclose.
Alexandria Wise-Brown, PhD	Dr. Wise-Brown has received personal compensation for serving as an employee of Genentech.
John Winslow, PhD	Dr. Winslow has received personal compensation for serving as an employee of Monogram Biosciences/Labcorp. Dr. Winslow has stock in Labcorp. Dr. Winslow has received intellectual property interests from a discovery or technology relating to health care.
Ahmed Chenna, PhD	Dr. Chenna has received personal compensation for serving as an employee of LabCorp-monogram Biosciences.
Christos J. Petropoulos, PhD	Dr. Petropoulos has received personal compensation for serving as an employee of Monogram Biosciences-Labcorp. Dr. Petropoulos has received stock or an ownership interest from Laboratory Corporation of America Holdings. Dr. Petropoulos has received intellectual property interests from a discovery or technology relating to health care.
Eoin Finegan, MBBS	Dr. Finegan has nothing to disclose.
Christian Wichmann	Dr. Wichmann has received personal compensation for serving as an employee of Novo Nordisk.
Marisa Whalen	Marisa Whalen has received personal compensation for serving as an employee of Jazz Pharmaceuticals.